WEBVTT - Here's How the New Weight Loss Drugs Could Change Everything

0:00:10.119 --> 0:00:13.400
<v Speaker 1>Hello, and welcome to another episode of the All Thoughts Podcast.

0:00:13.520 --> 0:00:14.880
<v Speaker 1>I'm Tracy Alloway.

0:00:14.560 --> 0:00:15.720
<v Speaker 2>And I'm Joe Wisenthal.

0:00:16.079 --> 0:00:18.520
<v Speaker 1>Joe, would you ever go on ozembic?

0:00:19.000 --> 0:00:19.160
<v Speaker 3>Oh?

0:00:19.239 --> 0:00:20.040
<v Speaker 2>Yeah, definitely?

0:00:20.280 --> 0:00:21.360
<v Speaker 3>Yeah?

0:00:21.400 --> 0:00:23.720
<v Speaker 2>Really well yeah, well not. This seems fun.

0:00:23.880 --> 0:00:27.440
<v Speaker 4>It reduces your appetite, probably lose weight. It seems like

0:00:27.480 --> 0:00:29.760
<v Speaker 4>it also has a bunch of other I keep seeing

0:00:29.760 --> 0:00:31.720
<v Speaker 4>these other things, like it's good for like, you know,

0:00:32.159 --> 0:00:35.639
<v Speaker 4>impulse control and all kinds of positive things that, yeah,

0:00:35.640 --> 0:00:35.880
<v Speaker 4>why not.

0:00:37.320 --> 0:00:39.879
<v Speaker 1>Yeah, it's supposed to be good for impulses and addiction.

0:00:40.240 --> 0:00:42.560
<v Speaker 1>And also I think there's some new stat out saying

0:00:42.560 --> 0:00:45.240
<v Speaker 1>that it reduces the risk of heart attack and stroke

0:00:45.280 --> 0:00:48.120
<v Speaker 1>by twenty percent. Well, anyway, who would you?

0:00:49.240 --> 0:00:49.680
<v Speaker 3>I think?

0:00:50.360 --> 0:00:54.120
<v Speaker 1>Yes, however, I would definitely wait for the price to

0:00:54.160 --> 0:00:57.400
<v Speaker 1>come down a little bit and maybe for more of

0:00:57.440 --> 0:01:00.680
<v Speaker 1>the side effects to become a parent, but I'm very

0:01:00.720 --> 0:01:04.280
<v Speaker 1>cautious with these sorts of medical breakthroughs.

0:01:04.520 --> 0:01:04.759
<v Speaker 5>Uh.

0:01:04.840 --> 0:01:07.200
<v Speaker 2>Yeah, I have to. I feel like my like, I

0:01:07.200 --> 0:01:07.800
<v Speaker 2>don't know that.

0:01:07.840 --> 0:01:10.520
<v Speaker 4>Much about all these drugs like ozimpic and mcgovey and

0:01:10.560 --> 0:01:13.760
<v Speaker 4>the other golp ones, but they seem pretty great, and

0:01:13.800 --> 0:01:16.920
<v Speaker 4>I'm just like, yeah, upward and onward. The March of

0:01:17.000 --> 0:01:20.280
<v Speaker 4>progress science. I love it, no, but I actually do

0:01:20.360 --> 0:01:22.679
<v Speaker 4>think like it is. Something I've been thinking about is

0:01:22.720 --> 0:01:26.399
<v Speaker 4>like people are so skeptical of even the possibility of

0:01:26.480 --> 0:01:28.080
<v Speaker 4>the existence of a wonder drug.

0:01:28.400 --> 0:01:29.520
<v Speaker 2>The people are like, Oh, it's.

0:01:29.360 --> 0:01:31.039
<v Speaker 4>Going to do this, it's going to do this, it's

0:01:31.040 --> 0:01:32.880
<v Speaker 4>going to be bad, it's going to reverse, it's going

0:01:32.920 --> 0:01:35.120
<v Speaker 4>to and maybe that's possible.

0:01:35.440 --> 0:01:37.039
<v Speaker 2>But what if it really is a wonder drug?

0:01:37.200 --> 0:01:39.680
<v Speaker 1>Well exactly, And I think it opens up a ton

0:01:39.840 --> 0:01:44.280
<v Speaker 1>of interesting questions, specifically about what it means for wider

0:01:44.400 --> 0:01:48.560
<v Speaker 1>society and the wider economy. When we know that obesity

0:01:48.960 --> 0:01:53.280
<v Speaker 1>and diseases like diabetes have been this huge weight on

0:01:53.600 --> 0:01:57.240
<v Speaker 1>both the socio economy and the healthcare industry.

0:01:57.560 --> 0:02:02.200
<v Speaker 4>Obesity itself is like just this gigantic economic force. It's

0:02:02.240 --> 0:02:05.480
<v Speaker 4>a business force. There are businesses that thrive on how

0:02:05.560 --> 0:02:07.920
<v Speaker 4>much people like to eat unhealthy foods.

0:02:07.920 --> 0:02:09.919
<v Speaker 2>They're huge costs to ensures.

0:02:10.000 --> 0:02:13.720
<v Speaker 4>There are other second order effects of related to injuries

0:02:13.760 --> 0:02:17.800
<v Speaker 4>and heart complications and so forth. It's such a modern

0:02:17.880 --> 0:02:21.440
<v Speaker 4>important phenomenon that we're there to be and maybe it

0:02:21.480 --> 0:02:22.520
<v Speaker 4>kind of looks like there is, but.

0:02:22.480 --> 0:02:23.360
<v Speaker 2>We're there to be.

0:02:23.440 --> 0:02:27.520
<v Speaker 4>This sort of like straightforward way to reduce obesity. It

0:02:27.520 --> 0:02:29.600
<v Speaker 4>seems like the implications would be huge.

0:02:29.360 --> 0:02:32.600
<v Speaker 1>Right, And I keep getting visions of like Star Trek

0:02:32.680 --> 0:02:34.920
<v Speaker 1>in my head where everyone is kind of slim and

0:02:35.000 --> 0:02:38.920
<v Speaker 1>dressed in tracks great and very athletically capable, and we

0:02:39.000 --> 0:02:41.600
<v Speaker 1>all just wander around spaceships. So that sounds great.

0:02:41.760 --> 0:02:41.919
<v Speaker 5>Well.

0:02:41.919 --> 0:02:44.160
<v Speaker 1>Anyway, on a serious note, I think we need to

0:02:44.200 --> 0:02:48.360
<v Speaker 1>dive into these new sets of drugs. What exactly are they,

0:02:48.560 --> 0:02:53.240
<v Speaker 1>how do they work, and more importantly, more interestingly, what

0:02:53.400 --> 0:02:56.480
<v Speaker 1>do they actually mean for the wider economy and the

0:02:56.520 --> 0:02:57.400
<v Speaker 1>business environment.

0:02:58.040 --> 0:03:00.360
<v Speaker 4>So many I'm so glad we're doing it because it

0:03:00.360 --> 0:03:03.799
<v Speaker 4>does feel like beyond just the companies selling these drugs,

0:03:03.800 --> 0:03:06.200
<v Speaker 4>which we know have been taken off. We're recording this

0:03:06.280 --> 0:03:10.079
<v Speaker 4>on August ninth. Just yesterday Nova and Nordis, the Danish company,

0:03:10.200 --> 0:03:13.400
<v Speaker 4>soared because they had another test showing that one of

0:03:13.400 --> 0:03:16.680
<v Speaker 4>these drugs was very good for fighting heart disease. So

0:03:16.720 --> 0:03:19.880
<v Speaker 4>we know that there's like the interest in the vendors

0:03:19.919 --> 0:03:22.280
<v Speaker 4>the sellers of these drugs. But again, what does it

0:03:22.320 --> 0:03:24.760
<v Speaker 4>mean all these second and third order effects if they

0:03:25.000 --> 0:03:27.240
<v Speaker 4>really become extremely widespread and it kind of looks like

0:03:27.240 --> 0:03:29.679
<v Speaker 4>they're on the trajectory feels very unexplored.

0:03:29.800 --> 0:03:33.120
<v Speaker 1>Yep, So let's dive into those second order effects of

0:03:33.200 --> 0:03:36.160
<v Speaker 1>miracle weight loss drugs. A fun episode ahead. We have

0:03:36.640 --> 0:03:39.120
<v Speaker 1>really the perfect guest. We're going to be speaking with

0:03:39.200 --> 0:03:43.640
<v Speaker 1>James Van Galen of Citrinidus Capital also known as Citrini

0:03:43.840 --> 0:03:46.200
<v Speaker 1>on Twitter. So, James, thank you so much for coming on.

0:03:46.200 --> 0:03:48.640
<v Speaker 5>All thoughts, Hi, Tracy, Joe, thanks for having me.

0:03:49.080 --> 0:03:52.880
<v Speaker 1>So, James, from what I remember, you actually have something

0:03:52.920 --> 0:03:54.680
<v Speaker 1>of a medical background. Is that right?

0:03:55.680 --> 0:03:57.880
<v Speaker 5>Yeah? I worked my way through undergrad as a paramedic

0:03:58.080 --> 0:04:00.600
<v Speaker 5>for a while in Bridgeport, Connecticut, and then when I

0:04:00.600 --> 0:04:04.920
<v Speaker 5>transferred to UCLA, I worked as a paramedic in Compton, California.

0:04:05.000 --> 0:04:07.760
<v Speaker 5>So I'm not a stranger to the medical field. Then

0:04:08.000 --> 0:04:11.840
<v Speaker 5>for about four years I started what co founded one

0:04:11.880 --> 0:04:16.200
<v Speaker 5>of Connecticut's first medical marijuana dispensaries. So I definitely am

0:04:16.240 --> 0:04:18.839
<v Speaker 5>not a stranger to the medical field. Now I do

0:04:18.880 --> 0:04:21.000
<v Speaker 5>the hedge fun thing, and it comes in andy once

0:04:21.040 --> 0:04:21.720
<v Speaker 5>in a while.

0:04:22.600 --> 0:04:27.360
<v Speaker 4>Investing in medical technology or sorry, you know, I or biotech.

0:04:27.400 --> 0:04:30.039
<v Speaker 4>Often it seems like the sort of like Roulette wheel,

0:04:30.040 --> 0:04:33.000
<v Speaker 4>And I'm always skeptical that anyone who is like not

0:04:33.120 --> 0:04:38.760
<v Speaker 4>a scientist can actually have informed insights on new medicines

0:04:38.800 --> 0:04:40.919
<v Speaker 4>and how big they could get, et cetera. Can you

0:04:40.960 --> 0:04:43.320
<v Speaker 4>just sort of like give your overview of like how

0:04:43.360 --> 0:04:45.280
<v Speaker 4>do you even like think about these things? Like if

0:04:45.320 --> 0:04:47.880
<v Speaker 4>you're not like a scientist, how do you even begin

0:04:47.960 --> 0:04:50.520
<v Speaker 4>to wrap your head around like how do these drugs work?

0:04:50.560 --> 0:04:52.640
<v Speaker 4>And how big they could be? And which ones I

0:04:52.680 --> 0:04:55.000
<v Speaker 4>have more potential than others? Like what's your like framework

0:04:55.040 --> 0:04:57.800
<v Speaker 4>for like sort of just like evaluating some breakthrough in

0:04:57.880 --> 0:04:58.440
<v Speaker 4>the first place.

0:04:59.360 --> 0:05:02.360
<v Speaker 5>I mean, I don't do a ton of like biopharma investing.

0:05:02.400 --> 0:05:04.560
<v Speaker 5>I'm not a scientist, but I do have a bus

0:05:04.920 --> 0:05:08.080
<v Speaker 5>network of channel checks and I'm a big proponent of

0:05:08.200 --> 0:05:11.280
<v Speaker 5>basically if you don't know something, ask you know, and

0:05:11.480 --> 0:05:15.880
<v Speaker 5>we are so so I am. You know, I'm always

0:05:15.920 --> 0:05:18.040
<v Speaker 5>bothering them, and you know I'll cost me as a

0:05:18.040 --> 0:05:20.800
<v Speaker 5>couple of dinners or something. And but you know, I

0:05:21.520 --> 0:05:25.040
<v Speaker 5>don't do much, if any investing in companies that are

0:05:25.080 --> 0:05:27.320
<v Speaker 5>still clinical stage, right, And you know, a lot of

0:05:27.360 --> 0:05:29.920
<v Speaker 5>my investing is kind of thematic investing. It's focused on

0:05:29.960 --> 0:05:33.040
<v Speaker 5>these kind of paradigm shifts, these mega trends essentially, and

0:05:33.480 --> 0:05:36.160
<v Speaker 5>when you see something like this, right, you know, all

0:05:36.200 --> 0:05:40.200
<v Speaker 5>the feedback from channel checks is good, and it's something

0:05:40.240 --> 0:05:42.520
<v Speaker 5>that we kind of needed as a you know, as

0:05:42.560 --> 0:05:46.279
<v Speaker 5>a in developed markets at least for decades, right, And

0:05:47.320 --> 0:05:50.839
<v Speaker 5>you just see the kind of behavioral incentives that exist

0:05:50.880 --> 0:05:54.039
<v Speaker 5>surrounding it. And I always come back to basically you

0:05:54.080 --> 0:05:57.120
<v Speaker 5>look at like viagra in the nineties, and you know,

0:05:57.160 --> 0:05:59.360
<v Speaker 5>you did not have to be a doctor to kind

0:05:59.400 --> 0:06:03.800
<v Speaker 5>of see Pfiser just killing it, you know, just doing

0:06:04.320 --> 0:06:07.599
<v Speaker 5>amazingly with this drug that solved the problem that people

0:06:07.600 --> 0:06:09.799
<v Speaker 5>had that you know, needed to be fixed and it worked.

0:06:09.880 --> 0:06:11.960
<v Speaker 5>And you know, honestly, that might be the reason that

0:06:12.000 --> 0:06:15.320
<v Speaker 5>most of us know who Phiser is, right. So you know,

0:06:15.520 --> 0:06:18.520
<v Speaker 5>whether it's buying Maderna when they're developing a co vaccine,

0:06:18.600 --> 0:06:20.680
<v Speaker 5>or buying Eli Lilly when they're developing, you know, a

0:06:20.680 --> 0:06:23.640
<v Speaker 5>fat vaccine, or a Pfiser with Bager in the nineties,

0:06:23.800 --> 0:06:26.920
<v Speaker 5>it all falls under the mega trend looking for kind

0:06:26.960 --> 0:06:28.760
<v Speaker 5>of these paradigm thematic shifts.

0:06:29.200 --> 0:06:32.919
<v Speaker 1>I think people forget nowadays that viagra was initially developed

0:06:32.960 --> 0:06:36.400
<v Speaker 1>for something totally different to what it's used, and that

0:06:36.640 --> 0:06:39.720
<v Speaker 1>happened to be a sort of happy side effect of

0:06:39.760 --> 0:06:42.000
<v Speaker 1>the medication. I guess and then it became known for that.

0:06:42.400 --> 0:06:45.400
<v Speaker 1>But just on this note, let me ask the basic question,

0:06:45.600 --> 0:06:49.839
<v Speaker 1>So how did these drugs gop one I'm not even

0:06:49.839 --> 0:06:52.440
<v Speaker 1>sure what that stands for, but how did these come

0:06:52.600 --> 0:06:56.200
<v Speaker 1>into being? And how are they starting to spread through

0:06:56.200 --> 0:07:00.000
<v Speaker 1>the market such that I meet vcs who will openly

0:07:00.120 --> 0:07:02.640
<v Speaker 1>say that they're on a zempic and I'm pretty sure

0:07:02.680 --> 0:07:05.320
<v Speaker 1>they don't actually have diabetes.

0:07:05.520 --> 0:07:08.480
<v Speaker 5>You know. So GOLP one stands for glucagon like peptide,

0:07:08.760 --> 0:07:10.040
<v Speaker 5>not to get I don't want to get like two

0:07:10.040 --> 0:07:14.480
<v Speaker 5>scientific but basically, the peptide helps kind of prime insulin release, right.

0:07:14.560 --> 0:07:17.240
<v Speaker 5>It allows the body to absorb glucose after a meal,

0:07:17.520 --> 0:07:19.560
<v Speaker 5>and you have specific cells in your pancreas that can

0:07:19.640 --> 0:07:23.320
<v Speaker 5>recognize GLP one through what molecules called receptors. Right. So

0:07:24.640 --> 0:07:27.840
<v Speaker 5>essentially we've been looking into these drugs you know, called peptider.

0:07:28.160 --> 0:07:29.960
<v Speaker 5>The medical field has been looking into them, you know,

0:07:30.040 --> 0:07:33.160
<v Speaker 5>since the seventies. And GLP one's primary benefit was the

0:07:33.160 --> 0:07:35.440
<v Speaker 5>fact that it was able to produce blood glucose levels

0:07:35.600 --> 0:07:38.680
<v Speaker 5>via insulin release, which is you know, very desirable in

0:07:38.720 --> 0:07:42.880
<v Speaker 5>a patient with diabetes. And the thing was the you know,

0:07:42.960 --> 0:07:45.640
<v Speaker 5>when it comes to peptides. Normally, you're trying to mimic

0:07:45.880 --> 0:07:48.520
<v Speaker 5>the peptide that your own body produces. So the actual

0:07:48.560 --> 0:07:52.480
<v Speaker 5>molecule glucagon like peptide one is only to able to

0:07:52.560 --> 0:07:56.560
<v Speaker 5>create these effects for a very short time span. And

0:07:56.800 --> 0:08:03.080
<v Speaker 5>so what these genius anders discovered was that they can

0:08:03.240 --> 0:08:07.080
<v Speaker 5>essentially mimic these hormones and have these molecules that bind

0:08:07.080 --> 0:08:09.960
<v Speaker 5>to the receptors they're called agonists, right, and that can

0:08:10.000 --> 0:08:12.800
<v Speaker 5>create an effect that lasts, you know, four hours or

0:08:12.800 --> 0:08:15.960
<v Speaker 5>even weeks. And that was basically the basis of the

0:08:16.000 --> 0:08:21.240
<v Speaker 5>initial development and the impetus for it was essentially to

0:08:21.840 --> 0:08:24.000
<v Speaker 5>go after diabetes. Right. If you have something that can

0:08:24.080 --> 0:08:28.080
<v Speaker 5>regulate glucose that is possibly dysregulated in a patient with diabetes,

0:08:28.720 --> 0:08:34.360
<v Speaker 5>that's kind of something that seems desirable, right. So they

0:08:34.360 --> 0:08:37.160
<v Speaker 5>were kind of predicted to also prolong this feeling of

0:08:37.200 --> 0:08:42.640
<v Speaker 5>you know, fullness and slow gastric emptying. And they also

0:08:42.679 --> 0:08:45.920
<v Speaker 5>provide a variety effects in the brain. And these drugs

0:08:46.000 --> 0:08:49.920
<v Speaker 5>do cross the blood brain barrier. And the first GLP

0:08:50.040 --> 0:08:53.679
<v Speaker 5>one drug that was approved by the FDA was Exenotide.

0:08:53.760 --> 0:08:56.959
<v Speaker 5>It was marketed under the name Bieta. So Bieta was

0:08:56.960 --> 0:09:00.160
<v Speaker 5>approved in two thousand and five, right, and primarily be

0:09:00.280 --> 0:09:04.360
<v Speaker 5>used in type two diabetes. And while you have something

0:09:04.400 --> 0:09:07.880
<v Speaker 5>like semic glutide right now, which is ozembic generic name frozenpic,

0:09:08.600 --> 0:09:12.560
<v Speaker 5>and then Munjaro, which is Lily's drug. Ters Appetite is

0:09:12.559 --> 0:09:16.680
<v Speaker 5>the generic fan. And the thing is once you have

0:09:16.760 --> 0:09:20.079
<v Speaker 5>a class of drugs, but you can kind of anticipate

0:09:20.679 --> 0:09:23.120
<v Speaker 5>what the side effect profile will be. It's not necessarily

0:09:23.200 --> 0:09:25.840
<v Speaker 5>that you can, you know, anticipate every single side effect,

0:09:25.880 --> 0:09:27.720
<v Speaker 5>but you kind of you get an idea of the

0:09:27.720 --> 0:09:31.040
<v Speaker 5>structural activity relationship. You get an idea of, you know,

0:09:31.120 --> 0:09:34.400
<v Speaker 5>this dose dependent curve and where side effects start becoming apparent.

0:09:34.559 --> 0:09:38.400
<v Speaker 5>And so with GLP ones they have side effects, right,

0:09:38.440 --> 0:09:42.120
<v Speaker 5>they have some gi side effects, and these GLP one

0:09:42.120 --> 0:09:45.160
<v Speaker 5>receptor agonists, like semic glutide, they can be pretty bad.

0:09:46.200 --> 0:09:50.880
<v Speaker 5>But what Lily saw was essentially it was decided that

0:09:50.880 --> 0:09:53.959
<v Speaker 5>they would try it to go after different receptors in

0:09:54.120 --> 0:09:56.800
<v Speaker 5>the same system, right, so they kind of get this.

0:09:56.960 --> 0:10:00.080
<v Speaker 5>It's got like Ter's Appetite. Munjaro is basically a a

0:10:00.200 --> 0:10:06.280
<v Speaker 5>dual GLP one receptor and then GIP receptor agonists. So

0:10:06.559 --> 0:10:09.640
<v Speaker 5>the way that that works is the GIP activity allows

0:10:09.679 --> 0:10:13.520
<v Speaker 5>you to take a higher dose before experiencing the side effects,

0:10:13.760 --> 0:10:17.160
<v Speaker 5>the GI side effects, and we also kind of know

0:10:17.280 --> 0:10:19.920
<v Speaker 5>you know these since these drugs, you know, Trulicity was

0:10:19.920 --> 0:10:22.040
<v Speaker 5>a big one that it was approven I think twenty

0:10:22.120 --> 0:10:25.320
<v Speaker 5>fourteen for type two diabetes. It saw very wide use.

0:10:25.360 --> 0:10:28.719
<v Speaker 5>So when you encounter someone and they're like, oh, you know, no,

0:10:28.880 --> 0:10:30.680
<v Speaker 5>for sure, these drugs are going to aunt your insides,

0:10:30.720 --> 0:10:32.640
<v Speaker 5>you know, like I don't. I don't blame them for

0:10:32.760 --> 0:10:35.040
<v Speaker 5>that because if you look at the history of weight

0:10:35.040 --> 0:10:39.360
<v Speaker 5>loss medication, you think Fenn Fenn, right, which like basically

0:10:39.400 --> 0:10:42.679
<v Speaker 5>melted your heart. Then you know vermon event, which was

0:10:42.720 --> 0:10:46.080
<v Speaker 5>like this genius invention where the scientists were like, well,

0:10:46.480 --> 0:10:49.840
<v Speaker 5>you know the cannabinoid receptors basically the receptors that THHC

0:10:49.920 --> 0:10:52.200
<v Speaker 5>act on, those make you hungry, So if we block

0:10:52.280 --> 0:10:55.240
<v Speaker 5>those receptors, then it should make you not hungry. And

0:10:55.280 --> 0:10:57.920
<v Speaker 5>it did. But you know what else the cannabinoid receptors

0:10:58.000 --> 0:11:01.160
<v Speaker 5>make you is happy. So I don't know how they

0:11:01.160 --> 0:11:03.080
<v Speaker 5>didn't see it as coming, but it made people very

0:11:03.120 --> 0:11:05.960
<v Speaker 5>sad and increase the likelihood that they would commit suicide.

0:11:06.320 --> 0:11:08.679
<v Speaker 5>And that so that drug was pulled very quickly, and

0:11:08.880 --> 0:11:10.680
<v Speaker 5>you know, you kind of look at the pass of

0:11:10.720 --> 0:11:13.440
<v Speaker 5>the weight loss industry. People take you know, tapeworm pills

0:11:13.480 --> 0:11:18.240
<v Speaker 5>and just doing absolutely insane things, and it's kind of like, Okay,

0:11:18.280 --> 0:11:21.840
<v Speaker 5>now you have this drug and the absolute worst concern,

0:11:21.880 --> 0:11:24.200
<v Speaker 5>you know that there's a warning on the FDA label

0:11:24.320 --> 0:11:27.440
<v Speaker 5>is that it may you know, it may result in

0:11:28.120 --> 0:11:31.200
<v Speaker 5>thyroid cancer. But the thing is the only time that

0:11:31.200 --> 0:11:33.440
<v Speaker 5>that's ever been observed with these gop one drugs is

0:11:33.440 --> 0:11:36.080
<v Speaker 5>in mice. And the thing about mice is when you're

0:11:36.080 --> 0:11:38.320
<v Speaker 5>doing a trial with a mouse, the mouse is not

0:11:38.360 --> 0:11:41.640
<v Speaker 5>going to tell you I can't handle these side effects anymore,

0:11:41.640 --> 0:11:44.400
<v Speaker 5>I'm going to stop taking the injection. Right, No mice

0:11:44.520 --> 0:11:48.680
<v Speaker 5>drop out of trial studies. So what happens is, you know,

0:11:48.800 --> 0:11:51.720
<v Speaker 5>like the if you were to take the equivalent dose

0:11:51.800 --> 0:11:55.920
<v Speaker 5>that caused you know, these endoprin cancers in mice, before

0:11:55.960 --> 0:11:58.920
<v Speaker 5>you reach that point, you would be so sick to

0:11:58.960 --> 0:12:01.880
<v Speaker 5>the level of not being able to function. And it

0:12:01.920 --> 0:12:04.280
<v Speaker 5>is so the dose was much much higher, and that,

0:12:04.360 --> 0:12:07.680
<v Speaker 5>you know, the it has not been observed in humans.

0:12:07.880 --> 0:12:11.640
<v Speaker 5>And the other thing is this is probably a little controversial,

0:12:11.640 --> 0:12:16.000
<v Speaker 5>but the fact is, like obesity is devastating, right, it

0:12:16.080 --> 0:12:19.280
<v Speaker 5>is absolutely terrible the way that increases mortality. I mean,

0:12:20.240 --> 0:12:23.520
<v Speaker 5>I'm going to drop some statistics that Lily dropped on

0:12:23.520 --> 0:12:25.480
<v Speaker 5>an earnings call, which is that you know, there are

0:12:25.520 --> 0:12:28.840
<v Speaker 5>two hundred and thirty six OBC related health conditions. Type

0:12:28.880 --> 0:12:31.320
<v Speaker 5>two diabetes risk is increased by two hundred and forty

0:12:31.320 --> 0:12:33.839
<v Speaker 5>three percent in people with obesity, heart disease by sixty

0:12:33.920 --> 0:12:36.720
<v Speaker 5>nine percent, high blood pressure by one hundred and thirteen percent,

0:12:36.880 --> 0:12:41.520
<v Speaker 5>high cholesterol by seventy four percent. And the contribution to

0:12:41.559 --> 0:12:46.199
<v Speaker 5>all course call all cause mortality is so significant that essentially,

0:12:46.280 --> 0:12:50.440
<v Speaker 5>if I had a drug that would again this has

0:12:50.480 --> 0:12:53.880
<v Speaker 5>never been observed in humans, It's probably not going to

0:12:53.920 --> 0:12:56.480
<v Speaker 5>be because of the relationship that I described with the dose.

0:12:56.600 --> 0:12:59.360
<v Speaker 5>But let's say I had a drug that one hundred percent,

0:12:59.400 --> 0:13:01.559
<v Speaker 5>no matter what, forty years you're going to develop that

0:13:01.600 --> 0:13:04.960
<v Speaker 5>word cancer from me. Even if that was the case,

0:13:05.640 --> 0:13:07.960
<v Speaker 5>if it also one hundred percent of the time made

0:13:07.960 --> 0:13:10.920
<v Speaker 5>you not opdes anymore, the net effect on your life

0:13:10.960 --> 0:13:12.440
<v Speaker 5>expectancy would still be positive.

0:13:30.480 --> 0:13:33.640
<v Speaker 4>You know, you mentioned in the beginning that you as

0:13:33.679 --> 0:13:36.800
<v Speaker 4>an investor, you like to think about people called paradigm

0:13:36.840 --> 0:13:40.720
<v Speaker 4>shifts or mega trends and so forth, and one of

0:13:40.760 --> 0:13:43.360
<v Speaker 4>the things that thinking about it in this context, and

0:13:43.400 --> 0:13:46.160
<v Speaker 4>I think there is a very good argument. I'm basically

0:13:46.280 --> 0:13:49.640
<v Speaker 4>sold that the rise of these drugs will constitute a

0:13:49.679 --> 0:13:51.800
<v Speaker 4>paradigm shift or a mega trend or something like that,

0:13:51.880 --> 0:13:53.840
<v Speaker 4>and I feel like many people buy that. But the

0:13:53.880 --> 0:13:57.640
<v Speaker 4>other thing is that like betting on mega trend often

0:13:57.760 --> 0:13:59.600
<v Speaker 4>is not trivial in terms of even if you could

0:13:59.600 --> 0:14:01.720
<v Speaker 4>predict the trend, you might not know what to invest in.

0:14:02.160 --> 0:14:05.240
<v Speaker 4>And so, you know, a good example might be say

0:14:05.320 --> 0:14:08.240
<v Speaker 4>like the rise of Chinese industry or something like that

0:14:08.320 --> 0:14:10.320
<v Speaker 4>over in the you know, in the twenty first century,

0:14:10.400 --> 0:14:13.360
<v Speaker 4>since it's entry into the WTO. And it's not like

0:14:13.440 --> 0:14:15.920
<v Speaker 4>I don't think like buying like Chinese stocks have like

0:14:16.000 --> 0:14:19.480
<v Speaker 4>been like some like extraordinary winner certainly like long stretches

0:14:19.520 --> 0:14:22.280
<v Speaker 4>of time where that doesn't work. So like, what's the

0:14:22.320 --> 0:14:28.160
<v Speaker 4>next step from identifying mega trend to then thinking about, okay,

0:14:28.360 --> 0:14:31.360
<v Speaker 4>these will be actual winners as public market investments.

0:14:32.200 --> 0:14:35.000
<v Speaker 5>Well, let me talk a little bit about hype, right,

0:14:35.080 --> 0:14:38.600
<v Speaker 5>You just had Dan Lobe and talking about how it's

0:14:38.720 --> 0:14:41.520
<v Speaker 5>more important to monitor you know, Reddit boards than it

0:14:41.600 --> 0:14:42.680
<v Speaker 5>is to monitor fund.

0:14:44.080 --> 0:14:48.120
<v Speaker 4>Baby Tracy's Tracy's message in her bloombergs.

0:14:48.160 --> 0:14:50.160
<v Speaker 5>Tracy's ready to ready to spend up a fun that

0:14:50.200 --> 0:14:52.720
<v Speaker 5>takes advantage of that. I think she's very proud of

0:14:52.720 --> 0:14:54.760
<v Speaker 5>the redd investors. What was that the guy in the

0:14:54.760 --> 0:14:56.480
<v Speaker 5>basement has the edge If that's the case.

0:14:56.600 --> 0:14:59.280
<v Speaker 1>Yeah, well it's all about the story, all about the narrative, right,

0:14:59.320 --> 0:15:02.440
<v Speaker 1>and the guy reading Reddit might have a better handle

0:15:02.480 --> 0:15:02.760
<v Speaker 1>on that.

0:15:03.240 --> 0:15:05.800
<v Speaker 5>But go ahead, right, this kind of you know, the

0:15:05.920 --> 0:15:09.240
<v Speaker 5>metic investing. So yeah, you guys, ever heard of the

0:15:09.240 --> 0:15:11.960
<v Speaker 5>Gardner hype cycle? Yeah? For those who haven't, the way

0:15:11.960 --> 0:15:14.200
<v Speaker 5>that it looks is you have this kind of parabolic

0:15:14.280 --> 0:15:17.840
<v Speaker 5>rise between the technology trigger and then the peak of

0:15:17.880 --> 0:15:23.840
<v Speaker 5>inflated expectations, and kind of the axiomatic way to give

0:15:23.880 --> 0:15:26.360
<v Speaker 5>an example of this would be the dot com bubble. Right.

0:15:26.360 --> 0:15:29.400
<v Speaker 5>You have the technology trigger, which is the Internet, and

0:15:29.440 --> 0:15:31.560
<v Speaker 5>then you it kind of goes parabolic all the way

0:15:31.640 --> 0:15:34.080
<v Speaker 5>up to the peak of inflated expectations, which would probably

0:15:34.080 --> 0:15:36.640
<v Speaker 5>be you know, in nineteen ninety nine pets dot com

0:15:36.680 --> 0:15:40.720
<v Speaker 5>type stuff where the things that are happening are absolutely ridiculous, right,

0:15:40.800 --> 0:15:44.600
<v Speaker 5>the forecasts are insane. And the thing about a mega

0:15:44.640 --> 0:15:48.280
<v Speaker 5>trend or you know, a theme that is persistent, is

0:15:48.680 --> 0:15:51.080
<v Speaker 5>it doesn't go unnoticed for very long. It can be

0:15:51.120 --> 0:15:53.360
<v Speaker 5>a significant amount of time. But you know, you speak

0:15:53.400 --> 0:15:55.560
<v Speaker 5>about like Chinese industry in the twenty first century, you know,

0:15:55.600 --> 0:15:58.640
<v Speaker 5>like there was a period of time where you could

0:15:58.640 --> 0:16:01.200
<v Speaker 5>have been early on that and you could have invested

0:16:01.200 --> 0:16:03.040
<v Speaker 5>and made excellent returns that you know, the peak of

0:16:03.080 --> 0:16:07.440
<v Speaker 5>inflated expectations, and then uh kind of exited before I

0:16:07.440 --> 0:16:11.160
<v Speaker 5>guess I think maybe there was kind of a byphasics,

0:16:11.200 --> 0:16:13.120
<v Speaker 5>so maybe it would have been the Asian currency crisis.

0:16:13.160 --> 0:16:15.840
<v Speaker 5>But the then what happens is you get this trophic

0:16:15.880 --> 0:16:19.880
<v Speaker 5>disillusionment right where it's like this technology isn't real. Everything

0:16:20.000 --> 0:16:23.200
<v Speaker 5>is kind of hyped up. It was all bs whatever. Right,

0:16:23.200 --> 0:16:26.000
<v Speaker 5>it's a bubble, and that's exactly it was a bubble.

0:16:26.120 --> 0:16:27.800
<v Speaker 5>And then you get this well, you know, the thing

0:16:28.200 --> 0:16:30.760
<v Speaker 5>funny thing is people say it's a bubble while it's

0:16:30.800 --> 0:16:33.720
<v Speaker 5>going up, which is kind of like when people say,

0:16:33.800 --> 0:16:35.520
<v Speaker 5>you know, like, okay.

0:16:35.080 --> 0:16:39.040
<v Speaker 4>This is the difference between a journal instor just a

0:16:39.080 --> 0:16:40.720
<v Speaker 4>bu blah blah blah blah, and then other people are.

0:16:40.760 --> 0:16:41.520
<v Speaker 2>Making a for chane.

0:16:41.640 --> 0:16:43.960
<v Speaker 4>It's like right, like you know, like this is why

0:16:44.360 --> 0:16:47.000
<v Speaker 4>no reporter should ever should ever get into trading.

0:16:48.960 --> 0:16:51.080
<v Speaker 5>I mean, you know, like how long was you know,

0:16:51.200 --> 0:16:54.120
<v Speaker 5>Bitcoin had a you know, awful year last year, but

0:16:54.360 --> 0:16:57.360
<v Speaker 5>like how long was it going up for before? You know,

0:16:57.400 --> 0:16:59.760
<v Speaker 5>like obviously it was a bubble. But like, you know,

0:16:59.760 --> 0:17:02.080
<v Speaker 5>that doesn't mean that you have to like be like

0:17:02.160 --> 0:17:04.399
<v Speaker 5>a monk about it. You don't have to have this

0:17:04.480 --> 0:17:07.760
<v Speaker 5>monastic view where God forbid I benefit from a bubble.

0:17:07.800 --> 0:17:10.719
<v Speaker 5>You know, those people are wrong. Who cares? So anyway,

0:17:10.720 --> 0:17:13.400
<v Speaker 5>you get to kind of this trave disillusionment. And then

0:17:13.440 --> 0:17:16.000
<v Speaker 5>the next phase is kind of the slope of enlightenment

0:17:16.080 --> 0:17:18.679
<v Speaker 5>where you know, you borrow a phrase from the VCS,

0:17:18.720 --> 0:17:21.000
<v Speaker 5>it gets democratized. You know, you can go out in

0:17:21.000 --> 0:17:22.480
<v Speaker 5>the street right now. If I got on the street

0:17:22.480 --> 0:17:24.639
<v Speaker 5>and I ask someone what the Internet is, they're going

0:17:24.680 --> 0:17:26.040
<v Speaker 5>to look at me like I have five heads. They

0:17:26.080 --> 0:17:27.840
<v Speaker 5>don't necessarily have to know how it works, but they

0:17:27.880 --> 0:17:30.080
<v Speaker 5>know what it is, right, And then you get the

0:17:30.119 --> 0:17:34.359
<v Speaker 5>plateau of productivity. In the prototypical Gardner hype cycle, the

0:17:34.359 --> 0:17:39.160
<v Speaker 5>plateau of productivity is actually below the peak of inflated expectations.

0:17:39.560 --> 0:17:42.480
<v Speaker 5>But I think most of the time in markets it's

0:17:42.600 --> 0:17:45.760
<v Speaker 5>actually higher. Obviously, there's a bit survivorship bias on this.

0:17:45.960 --> 0:17:48.959
<v Speaker 5>You know, nobody that owned pets dot Com benefited from

0:17:49.000 --> 0:17:54.240
<v Speaker 5>the plateau of productivity. But if you think about you know, Facebook, Amazon, Apple,

0:17:54.240 --> 0:17:57.280
<v Speaker 5>you know these you know they or even you know,

0:17:57.320 --> 0:17:59.480
<v Speaker 5>you look at like the nifty to fifty in the seventies, right,

0:17:59.560 --> 0:18:02.120
<v Speaker 5>like some of them have had very bad returns, like IBM.

0:18:02.240 --> 0:18:04.760
<v Speaker 5>But then you know, honeywell or carry your global you know,

0:18:04.800 --> 0:18:10.080
<v Speaker 5>you get the uptake on the GDP effect. And essentially

0:18:11.119 --> 0:18:13.160
<v Speaker 5>this is kind of the enemy of the mega trend,

0:18:13.240 --> 0:18:15.960
<v Speaker 5>right because it's very easy to recognize it in the beginning,

0:18:16.000 --> 0:18:18.879
<v Speaker 5>and then if you're too late with it, you're gonna

0:18:18.920 --> 0:18:21.720
<v Speaker 5>think that the peak of inflated expectations is just the

0:18:21.760 --> 0:18:25.960
<v Speaker 5>pullback right when it's not. You know, So this is

0:18:26.040 --> 0:18:30.359
<v Speaker 5>kind of something where it's good to continuously monitor whether

0:18:31.240 --> 0:18:33.560
<v Speaker 5>your thesis is playing out, whether it is actually had

0:18:33.600 --> 0:18:36.840
<v Speaker 5>you know, whether it's artificial intelligence or you know, like

0:18:36.880 --> 0:18:40.240
<v Speaker 5>you said, the rise of Chinese industry, or the Inflation

0:18:40.440 --> 0:18:43.840
<v Speaker 5>Reduction Act and the impact and impetus of fiscal spending

0:18:44.320 --> 0:18:47.040
<v Speaker 5>or you know, GLP one drugs that as long as

0:18:47.080 --> 0:18:48.840
<v Speaker 5>you are on top of it and you can see,

0:18:48.880 --> 0:18:51.359
<v Speaker 5>you know, what are the earnings expectations like and what

0:18:51.440 --> 0:18:53.520
<v Speaker 5>are the actually you know, like like Nvidia is probably

0:18:53.560 --> 0:18:56.840
<v Speaker 5>gonna you know, beaten raised for the next couple of years,

0:18:57.119 --> 0:18:58.520
<v Speaker 5>but then you you know, where is going to be

0:18:58.560 --> 0:19:02.600
<v Speaker 5>the point where the expectations aren't sustainable and when it

0:19:02.680 --> 0:19:05.240
<v Speaker 5>comes to you know, you said you wanted to talk

0:19:05.240 --> 0:19:08.239
<v Speaker 5>about the knock on effects, which kind of I mean,

0:19:08.320 --> 0:19:10.399
<v Speaker 5>that's my favorite part of these things, right, like like

0:19:10.440 --> 0:19:13.960
<v Speaker 5>when you actually capture a theme and you know, let

0:19:14.000 --> 0:19:15.359
<v Speaker 5>me ask you a question like do you think the

0:19:15.440 --> 0:19:16.840
<v Speaker 5>knock on effects are happening yet?

0:19:17.880 --> 0:19:20.679
<v Speaker 1>I don't know what the take up. So my impression

0:19:20.800 --> 0:19:23.159
<v Speaker 1>is that actually we should ask how much do these

0:19:23.240 --> 0:19:26.040
<v Speaker 1>drugs actually cost because my impression is that they're pretty

0:19:26.119 --> 0:19:30.800
<v Speaker 1>expensive and so they're not making huge inroads into the

0:19:30.840 --> 0:19:34.639
<v Speaker 1>general population just yet, but that could easily change.

0:19:35.280 --> 0:19:38.320
<v Speaker 5>Well, you know, right now, as far as weight loss

0:19:38.359 --> 0:19:43.720
<v Speaker 5>is concerned. As an FDA on label indication, Novo has monopoly, right.

0:19:43.800 --> 0:19:46.080
<v Speaker 5>Novo has wegov, which is the drug that you know

0:19:46.280 --> 0:19:49.520
<v Speaker 5>just was had the big headline about twenty percent production

0:19:49.720 --> 0:19:54.639
<v Speaker 5>in heart attack risk and essentially when they had you know,

0:19:54.680 --> 0:19:57.560
<v Speaker 5>they can much charge what they want, right, and the

0:19:57.600 --> 0:19:59.920
<v Speaker 5>way that it's going to develop is Lily's drugman jar

0:20:00.119 --> 0:20:03.240
<v Speaker 5>which is much more effective, and there are other drug

0:20:03.240 --> 0:20:05.800
<v Speaker 5>bredits true Tide which is still in clinical trials, but

0:20:06.160 --> 0:20:09.520
<v Speaker 5>Munjara will be approved for weight loss. But at the

0:20:09.600 --> 0:20:12.600
<v Speaker 5>end of this year, you know that was reaffirmed by

0:20:12.840 --> 0:20:14.840
<v Speaker 5>or within the next six months. Right, that was reaffirmed

0:20:14.840 --> 0:20:17.679
<v Speaker 5>by the Lee on their earnings call. And let me

0:20:17.720 --> 0:20:19.560
<v Speaker 5>get the answer to the question first, because I want

0:20:19.560 --> 0:20:21.440
<v Speaker 5>to go into something that's going to answer your question,

0:20:21.520 --> 0:20:23.800
<v Speaker 5>but I do want to assess, right, so you think

0:20:23.800 --> 0:20:25.960
<v Speaker 5>that the not going effects are happening yet no?

0:20:26.160 --> 0:20:29.200
<v Speaker 4>So actually I've been wondering about this because I actually

0:20:29.480 --> 0:20:31.320
<v Speaker 4>was kind of under the impression link. When are we

0:20:31.359 --> 0:20:35.520
<v Speaker 4>going to see a company crash on earnings because they say,

0:20:35.560 --> 0:20:38.800
<v Speaker 4>you know what, we're seeing our sales collapse because.

0:20:38.520 --> 0:20:40.160
<v Speaker 1>No one's eating our chips.

0:20:40.680 --> 0:20:42.680
<v Speaker 4>Has it come up on any like fast food calls?

0:20:42.760 --> 0:20:42.960
<v Speaker 2>Yet?

0:20:42.960 --> 0:20:46.560
<v Speaker 4>Has it come up on any like CpG company earnings

0:20:46.600 --> 0:20:49.080
<v Speaker 4>calls yet? Like I remember, like last quarter, like check

0:20:49.160 --> 0:20:51.920
<v Speaker 4>the textbook company said like, all right, we're running into

0:20:51.960 --> 0:20:55.000
<v Speaker 4>trouble because AI is like affecting our ability to sell

0:20:55.040 --> 0:20:56.760
<v Speaker 4>this product that helps people with their homework.

0:20:57.000 --> 0:20:58.920
<v Speaker 5>So have we seen someone will ever say that again.

0:20:59.119 --> 0:21:01.679
<v Speaker 5>You know that, right, Joe. Yeah, Now, even if it's happening,

0:21:01.880 --> 0:21:05.240
<v Speaker 5>no one will ever blame AI again, right, they know

0:21:05.280 --> 0:21:06.480
<v Speaker 5>what happened to Shtags.

0:21:06.720 --> 0:21:08.960
<v Speaker 4>So is there are the companies yet that are saying,

0:21:09.000 --> 0:21:11.960
<v Speaker 4>you know what, in our customer base, we're seeing a

0:21:12.080 --> 0:21:15.280
<v Speaker 4>change in consumption patterns of something because of these drugs

0:21:16.119 --> 0:21:17.720
<v Speaker 4>A ton really a ton?

0:21:18.080 --> 0:21:21.800
<v Speaker 5>Yeah? So just to go through a couple, right, and

0:21:21.840 --> 0:21:25.160
<v Speaker 5>this will answer your question Tracy right where First up, Yes,

0:21:25.200 --> 0:21:28.280
<v Speaker 5>the drugs are expensive. These drugs cost about eight hundred

0:21:28.320 --> 0:21:30.240
<v Speaker 5>to twelve hundred dollars a month, you know which is

0:21:30.359 --> 0:21:34.359
<v Speaker 5>a lot, and that is for ozembic gob And like

0:21:34.400 --> 0:21:36.280
<v Speaker 5>I said, you know, you don't have anything that makes

0:21:36.359 --> 0:21:40.800
<v Speaker 5>this much money that doesn't have competition. Right, So, yes,

0:21:40.880 --> 0:21:43.320
<v Speaker 5>Lily will get approved for Munjaro on weight loss and

0:21:43.359 --> 0:21:45.600
<v Speaker 5>then there will be a duopoly and that'll probably last,

0:21:46.320 --> 0:21:47.879
<v Speaker 5>I don't know, you know, anywhere from a year to

0:21:47.920 --> 0:21:50.800
<v Speaker 5>three years or something like that. But to come back

0:21:50.840 --> 0:21:55.440
<v Speaker 5>to Viagra, right, if you think about it, Viagra in

0:21:55.800 --> 0:21:59.080
<v Speaker 5>nineteen ninety eight cost eighty eight dollars a pill. Okay,

0:21:59.160 --> 0:22:04.040
<v Speaker 5>now it costs two. There there is whether it's through generics,

0:22:04.040 --> 0:22:07.080
<v Speaker 5>whether it's through competition, you know, the cialis what the

0:22:07.160 --> 0:22:08.560
<v Speaker 5>way that it works is, you know, you have you

0:22:08.560 --> 0:22:12.600
<v Speaker 5>have competition, you have economies of scale, you have insurance coverage,

0:22:12.720 --> 0:22:16.560
<v Speaker 5>you have you know, the generic drugs. Eventually, glp ones,

0:22:16.560 --> 0:22:19.359
<v Speaker 5>in fact, in twenty thirty one will face mandatory discounting

0:22:19.400 --> 0:22:23.560
<v Speaker 5>under the Inflation Production Act. So are they expensive right now? Yeah?

0:22:24.040 --> 0:22:27.040
<v Speaker 5>But and to come back to what we were saying

0:22:27.080 --> 0:22:30.600
<v Speaker 5>before that still did not you know, GLP ones were

0:22:30.640 --> 0:22:33.679
<v Speaker 5>mentioned a thousand times in the in the in the

0:22:33.800 --> 0:22:37.040
<v Speaker 5>Q two Q three earnings. Wow, that's interesting. Only half

0:22:37.080 --> 0:22:39.080
<v Speaker 5>of that was by pharmaceutical companies.

0:22:39.240 --> 0:22:43.119
<v Speaker 1>Okay, I just I just did a transcript search and

0:22:43.200 --> 0:22:46.280
<v Speaker 1>there's a there's a Herbal Life earnings transcript where they

0:22:46.320 --> 0:22:50.680
<v Speaker 1>talk about GLP one drugs, like possibly back in the business.

0:22:51.240 --> 0:22:54.359
<v Speaker 5>I will never short Herbal Life just because we also

0:22:54.440 --> 0:22:57.680
<v Speaker 5>what happened with that. I am always willing to learn

0:22:57.680 --> 0:23:00.240
<v Speaker 5>from another person's mistake. And you know, like, but of

0:23:00.280 --> 0:23:02.040
<v Speaker 5>luck to actman if he wants to go after it again.

0:23:02.119 --> 0:23:05.240
<v Speaker 5>But you know, if you have documents searched up, Tracy,

0:23:05.280 --> 0:23:10.520
<v Speaker 5>you can look at metafest yeah, and metafest Yeah, Metafest.

0:23:10.560 --> 0:23:13.720
<v Speaker 5>They heerbal life didn't get hit as bad. But you know,

0:23:13.760 --> 0:23:15.359
<v Speaker 5>I don't know if that's I don't know what that

0:23:15.480 --> 0:23:17.600
<v Speaker 5>was a function of. I think they tried to explain it.

0:23:17.640 --> 0:23:21.200
<v Speaker 5>I didn't really vibe with the explanation, but Metafest basically

0:23:21.320 --> 0:23:24.560
<v Speaker 5>said that, you know, we're we sell things that you know,

0:23:24.600 --> 0:23:28.480
<v Speaker 5>people use to lose weight, and there's like we cannot

0:23:28.520 --> 0:23:32.800
<v Speaker 5>handle the competition from a drug that actually works, right

0:23:32.880 --> 0:23:35.320
<v Speaker 5>that they you know, I think the direct quote is that,

0:23:35.359 --> 0:23:39.280
<v Speaker 5>you know, customer acquisition is being pressured by GLP ones.

0:23:39.280 --> 0:23:41.800
<v Speaker 5>But you know what they're doing now. Their strategy is

0:23:41.880 --> 0:23:46.399
<v Speaker 5>essentially okay, let's do it too, you know, yeah, everyone

0:23:46.400 --> 0:23:51.439
<v Speaker 5>else's maybe right, just do something similar, yeah, exactly, and

0:23:51.480 --> 0:23:53.800
<v Speaker 5>that you know, like I love a company that is

0:23:53.880 --> 0:23:58.080
<v Speaker 5>like torqued up levered melting price like a melting ice cube,

0:23:58.520 --> 0:24:01.679
<v Speaker 5>and then position and right in the center of like

0:24:01.760 --> 0:24:05.280
<v Speaker 5>a you know, like a burgeoning you know, huge trend,

0:24:05.400 --> 0:24:09.080
<v Speaker 5>right because you know, like a good example from another trend,

0:24:09.200 --> 0:24:11.879
<v Speaker 5>artificial intelligence would be like applied opt to electronics, right,

0:24:11.920 --> 0:24:15.080
<v Speaker 5>which is like like it was destroyed and then you know,

0:24:15.440 --> 0:24:18.119
<v Speaker 5>with eight hundred G and the data center demand for

0:24:18.720 --> 0:24:25.399
<v Speaker 5>optical you know, it's a we're so back right, It

0:24:25.520 --> 0:24:25.760
<v Speaker 5>was so.

0:24:26.200 --> 0:24:28.480
<v Speaker 4>But I hadn't heard of Metafest, but I'm reading their

0:24:28.520 --> 0:24:32.199
<v Speaker 4>descriptions and among the things that they and among the

0:24:32.240 --> 0:24:36.760
<v Speaker 4>things that they make are pretzels, puff cereal, crunch drinks,

0:24:36.840 --> 0:24:40.600
<v Speaker 4>hearty choices, oatmeal, pancakes, pudding. So I'm basically I don't

0:24:40.640 --> 0:24:43.560
<v Speaker 4>know that maybe the products are delicious, but I'm imagining

0:24:43.600 --> 0:24:45.560
<v Speaker 4>the type of things that people who are sort of

0:24:45.600 --> 0:24:48.320
<v Speaker 4>like really trying to lose weight are, Like, I'm going

0:24:48.359 --> 0:24:50.800
<v Speaker 4>to eat these puffs and shakes because they're a little

0:24:50.800 --> 0:24:52.159
<v Speaker 4>bit healthier than the alternative.

0:24:52.600 --> 0:24:53.840
<v Speaker 5>I mean, you don't need to That's the thing you

0:24:53.840 --> 0:24:55.119
<v Speaker 5>don't need to work like, like, you know, I was

0:24:55.119 --> 0:24:58.359
<v Speaker 5>talking about my channel checks earlier, and I have an

0:24:58.480 --> 0:25:01.000
<v Speaker 5>end of chronologist, you know, like Eli Lily was one

0:25:01.000 --> 0:25:03.320
<v Speaker 5>of my biggest positions from you know, twenty twenty two,

0:25:03.400 --> 0:25:06.800
<v Speaker 5>twenty twenty one even, and it kind of got surpassed

0:25:06.880 --> 0:25:09.840
<v Speaker 5>during the AI stuff. But I built up a basically,

0:25:09.920 --> 0:25:11.199
<v Speaker 5>you know, like I would go to like an end up.

0:25:11.560 --> 0:25:13.359
<v Speaker 5>Whenever you have a position that's super big, you know

0:25:13.359 --> 0:25:15.640
<v Speaker 5>you're on top of it, right, and you can expense

0:25:15.680 --> 0:25:19.560
<v Speaker 5>a trip to enoprenologist conference and you go there and

0:25:19.720 --> 0:25:21.600
<v Speaker 5>like I'm speaking to these people and they're like, I

0:25:21.640 --> 0:25:25.480
<v Speaker 5>have a patient who was eating five thousand calories a day,

0:25:25.720 --> 0:25:28.320
<v Speaker 5>which is like a full time job, right, like like

0:25:28.680 --> 0:25:30.399
<v Speaker 5>five thousand. Once you get to like five thousand and

0:25:30.440 --> 0:25:33.159
<v Speaker 5>six thousand calories, that's like I mean that that is

0:25:33.200 --> 0:25:35.840
<v Speaker 5>like eight full meals a day, right, And he's like,

0:25:36.160 --> 0:25:39.880
<v Speaker 5>I am, he's having issues because I have to recommend

0:25:39.880 --> 0:25:43.800
<v Speaker 5>protein supplementation because he can't get above five hundred calories

0:25:43.800 --> 0:25:46.040
<v Speaker 5>a day. So if you look at a company like Metafest,

0:25:46.119 --> 0:25:49.480
<v Speaker 5>that's basically you know, selling this food that's a little

0:25:49.480 --> 0:25:51.520
<v Speaker 5>bit healthier for you and you know, maybe taste the

0:25:51.560 --> 0:25:53.960
<v Speaker 5>same so that you know you don't have to you're

0:25:54.040 --> 0:25:57.000
<v Speaker 5>kind of getting better macronutrients or something. I mean, there

0:25:57.080 --> 0:25:59.720
<v Speaker 5>might be an opportunity there for the protein shakes, but overall,

0:25:59.840 --> 0:26:01.920
<v Speaker 5>like you don't really need to worry about if you're

0:26:01.920 --> 0:26:03.680
<v Speaker 5>taking this struggle, you don't really need to worry about,

0:26:03.720 --> 0:26:05.679
<v Speaker 5>uh oh, you know, let me buy food that's like

0:26:05.760 --> 0:26:09.040
<v Speaker 5>more that's less calorically dense, because like it doesn't matter,

0:26:09.040 --> 0:26:11.600
<v Speaker 5>you're not going to eat it anyway. And this is

0:26:11.680 --> 0:26:14.400
<v Speaker 5>kind of interesting because when you're looking at when you're

0:26:14.400 --> 0:26:17.159
<v Speaker 5>like monitoring social media, you know, like always monitoring, like

0:26:17.200 --> 0:26:20.520
<v Speaker 5>you know, Google trends, Wikipedia trends, and for a little bit,

0:26:20.840 --> 0:26:22.520
<v Speaker 5>I think this was like the middle of last year,

0:26:23.000 --> 0:26:25.240
<v Speaker 5>you know, monitoring Google trends, and this Google trend comes

0:26:25.320 --> 0:26:26.560
<v Speaker 5>up called ozempic face.

0:26:27.640 --> 0:26:31.440
<v Speaker 1>Oh yeah, people get really gone from weight loss.

0:26:31.880 --> 0:26:34.040
<v Speaker 5>Literally like I had, and I'm like my fingers on

0:26:34.160 --> 0:26:36.359
<v Speaker 5>the sell button. I'm like if it affects your face,

0:26:36.400 --> 0:26:39.600
<v Speaker 5>like I'm out, you know, And it turns out like

0:26:39.640 --> 0:26:42.199
<v Speaker 5>people were like, oh god, like ozempic causes you to

0:26:42.240 --> 0:26:44.240
<v Speaker 5>have like, you know, like a gaunt face or something,

0:26:44.280 --> 0:26:47.720
<v Speaker 5>and it's like not really, what's causing you to look

0:26:47.800 --> 0:26:50.080
<v Speaker 5>gaune is the fact that you're losing a ton of

0:26:50.080 --> 0:26:52.640
<v Speaker 5>weight very quickly. Right. And you have another one where

0:26:52.680 --> 0:26:54.760
<v Speaker 5>like people are like worried about hair loss and you

0:26:54.800 --> 0:26:58.479
<v Speaker 5>know that is it's a condition called intelligent effluvium, right,

0:26:58.480 --> 0:27:00.679
<v Speaker 5>which is basically the same thing when you lose too

0:27:00.760 --> 0:27:03.639
<v Speaker 5>much weight. You you know, your body is kind of

0:27:03.680 --> 0:27:06.480
<v Speaker 5>like burning nutrients for energy. You're at a caloric deficit

0:27:06.560 --> 0:27:09.840
<v Speaker 5>and you lose cair it's totally reversible, and with like

0:27:09.840 --> 0:27:12.399
<v Speaker 5>ozembic face, It's like you can't see wrinkles on like

0:27:12.400 --> 0:27:15.879
<v Speaker 5>an inflated balloon, right like it that's just how it works.

0:27:15.920 --> 0:27:19.600
<v Speaker 5>And it's kind of amazing to me because you have

0:27:19.800 --> 0:27:22.840
<v Speaker 5>this kind of imphasis where people are like, oh, like

0:27:22.920 --> 0:27:25.080
<v Speaker 5>this is that, this is the side like we gotcha,

0:27:25.280 --> 0:27:27.119
<v Speaker 5>you know, like this is I knew there was going

0:27:27.160 --> 0:27:29.120
<v Speaker 5>to be a catch. And it's like people are so

0:27:29.200 --> 0:27:32.040
<v Speaker 5>unaccustomed to the idea of there being a weight loss

0:27:32.119 --> 0:27:35.600
<v Speaker 5>drug that works that they are confusing the side effects

0:27:35.600 --> 0:27:37.840
<v Speaker 5>of the drug with the side effects of the effects

0:27:37.880 --> 0:27:40.840
<v Speaker 5>of the drug, which is you know, success being successful

0:27:40.880 --> 0:27:41.480
<v Speaker 5>weight loss just.

0:27:41.520 --> 0:27:42.120
<v Speaker 2>For voice worth.

0:27:42.160 --> 0:27:44.159
<v Speaker 4>I'm sorry, I keep going back this. I'm reading the

0:27:44.280 --> 0:27:46.720
<v Speaker 4>metafest transcript from earlier in the week and one of

0:27:46.720 --> 0:27:49.880
<v Speaker 4>the one of the questions is rbal life doesn't say anything.

0:27:49.960 --> 0:27:50.840
<v Speaker 2>I'm paraphrasing.

0:27:51.080 --> 0:27:53.640
<v Speaker 4>Well, one of the questions from the analysts is erbal

0:27:53.680 --> 0:27:56.720
<v Speaker 4>life didn't say anything about GLP one drugs affecting their business?

0:27:56.760 --> 0:27:58.359
<v Speaker 2>What about you? And they're like, well, we're not going

0:27:58.440 --> 0:27:59.040
<v Speaker 2>to comment.

0:27:58.840 --> 0:28:01.000
<v Speaker 4>On rbal life, but yeah, we're feeling it, so yeah,

0:28:01.000 --> 0:28:03.800
<v Speaker 4>it actually it came up. They also cited higher customer

0:28:03.840 --> 0:28:07.440
<v Speaker 4>acquisition costs. Again, they say, pressured by less prospects being

0:28:07.480 --> 0:28:11.760
<v Speaker 4>identified by coaches, impacted by competition from GLP one drugs,

0:28:11.960 --> 0:28:12.879
<v Speaker 4>inflationary pressure.

0:28:12.920 --> 0:28:13.719
<v Speaker 2>So it's coming up.

0:28:13.960 --> 0:28:15.840
<v Speaker 1>Wait, so can I ask you a basic question?

0:28:16.160 --> 0:28:16.280
<v Speaker 5>Wait?

0:28:16.320 --> 0:28:18.040
<v Speaker 1>Wait, just before we go further, can I ask a

0:28:18.040 --> 0:28:20.560
<v Speaker 1>basic question, which is, like how many people are on

0:28:20.680 --> 0:28:22.080
<v Speaker 1>these drugs right now?

0:28:23.560 --> 0:28:26.879
<v Speaker 5>I mean, so I would rather not comment, right, I

0:28:27.200 --> 0:28:29.560
<v Speaker 5>think that I would never be talking about something like

0:28:29.560 --> 0:28:31.560
<v Speaker 5>this if I didn't think that it was early, right,

0:28:31.640 --> 0:28:35.320
<v Speaker 5>and the so like you can look at penetration like

0:28:35.359 --> 0:28:39.000
<v Speaker 5>type two diabetes, right, you know, talking about like penetration

0:28:39.160 --> 0:28:41.120
<v Speaker 5>of a drug that's been approved for an indication for

0:28:41.400 --> 0:28:43.560
<v Speaker 5>a year. You know, it's like you're not really going

0:28:43.640 --> 0:28:46.200
<v Speaker 5>to get an accurate picture, you know, majarro And also

0:28:46.240 --> 0:28:48.320
<v Speaker 5>a drug where like there's only been one approved for

0:28:48.560 --> 0:28:51.080
<v Speaker 5>you know, and then you get also the fact that

0:28:51.200 --> 0:28:54.200
<v Speaker 5>like there are talking about, you know, mentions on earnings.

0:28:54.720 --> 0:28:58.560
<v Speaker 5>There are significant supply chain issues with these drugs right now,

0:28:58.680 --> 0:29:02.240
<v Speaker 5>like like Novo's having trouble sourcing the drugs coming in

0:29:02.360 --> 0:29:05.080
<v Speaker 5>autoinjector right, which is basically if you think of an EpiPen,

0:29:05.400 --> 0:29:07.440
<v Speaker 5>you know, you take it once a week and you

0:29:07.480 --> 0:29:09.640
<v Speaker 5>know it's like a button that you wish but you

0:29:09.640 --> 0:29:12.720
<v Speaker 5>look at like like talking still about like the earnings mentions,

0:29:12.800 --> 0:29:18.440
<v Speaker 5>if you look at Stevenado or Garretsheimer or even Beckton Dickinson.

0:29:18.960 --> 0:29:21.520
<v Speaker 5>The problem is that they can't produce enough of it,

0:29:21.640 --> 0:29:23.719
<v Speaker 5>which would tell you something about demand, right, like, like

0:29:23.800 --> 0:29:24.120
<v Speaker 5>even I.

0:29:24.200 --> 0:29:26.840
<v Speaker 1>Know this would turn into a supply chain episode eventually.

0:29:28.680 --> 0:29:30.080
<v Speaker 5>Please don't try to get me to talk about the

0:29:30.080 --> 0:29:33.920
<v Speaker 5>sly chainer so I will seem very silly. But the

0:29:34.000 --> 0:29:37.600
<v Speaker 5>thing is just even Lily, right, Obviously they have to

0:29:37.640 --> 0:29:41.560
<v Speaker 5>temper their optimism, but they're having to ramp up production

0:29:41.760 --> 0:29:45.440
<v Speaker 5>at all, you know, five global facilities just because of

0:29:45.480 --> 0:29:47.720
<v Speaker 5>the fact that like they're like overwhelmed. They could not

0:29:47.840 --> 0:29:53.479
<v Speaker 5>even have anticipated this level of demand. Right during Lily's

0:29:53.520 --> 0:29:56.720
<v Speaker 5>earnings call, Chris Shibatani and analyst was asking a question

0:29:56.760 --> 0:29:59.840
<v Speaker 5>that was basically like Novo and Lily, you've been confronted

0:29:59.840 --> 0:30:02.400
<v Speaker 5>by this demand that was like beyond what you could

0:30:02.440 --> 0:30:06.560
<v Speaker 5>have possibly planned for. And with Lily, you know, Majar

0:30:06.720 --> 0:30:09.760
<v Speaker 5>isn't even a proof for weight loss yet, and so

0:30:11.080 --> 0:30:14.760
<v Speaker 5>essentially it would be kind of premature to say, you

0:30:14.760 --> 0:30:17.240
<v Speaker 5>know what the penetration of these drugs is right now.

0:30:17.680 --> 0:30:21.280
<v Speaker 5>But what I will say is that and I have

0:30:21.320 --> 0:30:22.920
<v Speaker 5>a chart that I can you know, send you maybe

0:30:22.920 --> 0:30:26.840
<v Speaker 5>can put it up on the site that essentially the

0:30:26.880 --> 0:30:29.760
<v Speaker 5>obesity rate in the US in nineteen seventy four was

0:30:29.800 --> 0:30:33.000
<v Speaker 5>twelve percent, right, and now it's forty two percent. And

0:30:33.120 --> 0:30:36.040
<v Speaker 5>for the past five decades, there have not been two

0:30:36.160 --> 0:30:39.320
<v Speaker 5>sequential years in which the obescd rate has ticked down.

0:30:39.760 --> 0:30:45.040
<v Speaker 5>It hasn't happened for fifty years. So you know, when

0:30:45.040 --> 0:30:47.080
<v Speaker 5>you look at that, I first off, I think it's

0:30:47.240 --> 0:30:51.200
<v Speaker 5>not just reasonable but rational to think that you can't

0:30:51.200 --> 0:30:54.400
<v Speaker 5>have a society that has both advanced medication and then

0:30:55.240 --> 0:30:58.440
<v Speaker 5>half of its populace affected by a disease and not

0:30:58.480 --> 0:31:01.240
<v Speaker 5>think that eventually those two things were resolve each other. Right.

0:31:02.200 --> 0:31:04.400
<v Speaker 5>And if you look at the sixty eight week trial

0:31:04.480 --> 0:31:07.840
<v Speaker 5>data Munjarro, and you adjust for you know, the average compliance,

0:31:07.920 --> 0:31:11.360
<v Speaker 5>and you know which patients dropped out prematurely, and then

0:31:11.840 --> 0:31:15.160
<v Speaker 5>you adjust for the fact that about after you drop

0:31:15.200 --> 0:31:17.640
<v Speaker 5>out of the trial, about half of the weight loss

0:31:17.760 --> 0:31:20.760
<v Speaker 5>you still maintained about half of the weight that you lost,

0:31:20.760 --> 0:31:23.840
<v Speaker 5>but about half of it goes away, and so you

0:31:23.880 --> 0:31:27.160
<v Speaker 5>adjust for all those things. If Munjaro a sixty eight

0:31:27.160 --> 0:31:30.959
<v Speaker 5>week trial data has a thirty percent penetration rate in

0:31:31.240 --> 0:31:35.160
<v Speaker 5>the obese population. Right, the obeset rate in the United

0:31:35.200 --> 0:31:37.640
<v Speaker 5>States would be lower than it was in nineteen ninety seven.

0:31:38.200 --> 0:31:41.000
<v Speaker 5>And you know, like that could happen over the course

0:31:41.040 --> 0:31:43.880
<v Speaker 5>of two or three years. And so for a line

0:31:43.880 --> 0:31:45.960
<v Speaker 5>that has gone up into the right to go down,

0:31:46.080 --> 0:31:59.880
<v Speaker 5>you know that significantly.

0:32:04.120 --> 0:32:08.560
<v Speaker 4>So I'm not surprised that, you know, mentions of GOLP

0:32:08.720 --> 0:32:11.959
<v Speaker 4>onees are popping up on various conference calls. You know,

0:32:12.040 --> 0:32:14.680
<v Speaker 4>some obvious ways, like the company that maybe makes the

0:32:14.960 --> 0:32:18.040
<v Speaker 4>devices for its use, or the companies that have some

0:32:18.240 --> 0:32:21.800
<v Speaker 4>other weight loss solution that may be feeling pressure. But

0:32:22.000 --> 0:32:26.080
<v Speaker 4>like for example, today again August ninth, we got earnings

0:32:26.080 --> 0:32:30.520
<v Speaker 4>from Wendy's. No mention of GLP one there. Yet I

0:32:30.520 --> 0:32:33.680
<v Speaker 4>looked last month, we got earnings from PEPSI. And you know,

0:32:33.680 --> 0:32:36.600
<v Speaker 4>if I were to think about, like, okay, in theory,

0:32:36.800 --> 0:32:39.840
<v Speaker 4>in some future world where these drugs are very cheap

0:32:40.040 --> 0:32:45.560
<v Speaker 4>and widespread, and who would theoretically be losers from drugs

0:32:45.600 --> 0:32:49.880
<v Speaker 4>that reduce one's appetite for fast food, for salty foods,

0:32:49.880 --> 0:32:53.560
<v Speaker 4>for high carb foods, whatever it is in your mind,

0:32:53.680 --> 0:32:56.480
<v Speaker 4>is it obvious that A some of these big consumer

0:32:56.520 --> 0:32:59.200
<v Speaker 4>oriented companies are going to be losers, and B if

0:32:59.240 --> 0:33:02.520
<v Speaker 4>it is, when would you expect to see, like what

0:33:02.680 --> 0:33:05.440
<v Speaker 4>pick a predicted quarter when maybe this would.

0:33:05.240 --> 0:33:06.600
<v Speaker 2>Come up on a Wendy's earnings call.

0:33:07.480 --> 0:33:10.200
<v Speaker 5>Well, so let's think, you know, first off.

0:33:10.080 --> 0:33:12.720
<v Speaker 4>Or or if the premise of the question is totally

0:33:12.720 --> 0:33:13.640
<v Speaker 4>off the mark, that's fine too.

0:33:14.200 --> 0:33:16.040
<v Speaker 5>No, no, no, I mean it's a it's a I don't know,

0:33:16.080 --> 0:33:18.120
<v Speaker 5>we're talking about second order effects that this seems a

0:33:18.160 --> 0:33:22.200
<v Speaker 5>little first order Joe, Okay, you're right, you're right. No,

0:33:22.240 --> 0:33:24.240
<v Speaker 5>but no, no, I mean it's a great point, right,

0:33:24.320 --> 0:33:26.920
<v Speaker 5>And I think that the sent I mean, you know,

0:33:27.040 --> 0:33:32.280
<v Speaker 5>Wendy's sells so much food right like it's it's uh

0:33:32.320 --> 0:33:35.360
<v Speaker 5>me too. I don't want to I don't want to

0:33:35.400 --> 0:33:37.880
<v Speaker 5>malign Wendy's. But the thing is, I think that if

0:33:37.920 --> 0:33:39.640
<v Speaker 5>you wanted to be able to predict this, what you

0:33:39.640 --> 0:33:42.239
<v Speaker 5>would have to do is you'd probably have to use

0:33:42.240 --> 0:33:44.680
<v Speaker 5>all data or you know, credit card data, and you

0:33:44.680 --> 0:33:47.120
<v Speaker 5>would have to look at the company and maybe eat

0:33:47.120 --> 0:33:48.960
<v Speaker 5>a lot of fast foods for a month to figure out.

0:33:49.000 --> 0:33:54.440
<v Speaker 5>But like, which of these companies you're going to be

0:33:54.480 --> 0:33:57.360
<v Speaker 5>my new analyst. No, which of these companies are willing

0:33:57.640 --> 0:34:01.520
<v Speaker 5>to or are basically making up for or low margins

0:34:01.560 --> 0:34:04.360
<v Speaker 5>with high volumes, right because the because it's not like

0:34:04.400 --> 0:34:07.520
<v Speaker 5>these drugs are going to automatically make you, you know

0:34:07.760 --> 0:34:10.200
<v Speaker 5>the Jack Lalane right, Like, you're not gonna You're not

0:34:10.239 --> 0:34:12.360
<v Speaker 5>just gonna be like the hell you all your habits

0:34:12.360 --> 0:34:15.120
<v Speaker 5>are healthy now, Like if you're eating fast food every day,

0:34:15.120 --> 0:34:17.319
<v Speaker 5>you will probably continue to eat fast food every day.

0:34:17.320 --> 0:34:19.319
<v Speaker 5>You will just eat a lot less of it, like

0:34:19.400 --> 0:34:24.000
<v Speaker 5>a lot less of it. And let's say chapatte for example, Yeah,

0:34:24.080 --> 0:34:26.279
<v Speaker 5>probably not going to be that negatively affected, you know,

0:34:26.400 --> 0:34:28.600
<v Speaker 5>like like people you know, they'll probably have the same

0:34:28.760 --> 0:34:30.360
<v Speaker 5>order and they'll just finish, you know, a couple of

0:34:30.360 --> 0:34:33.200
<v Speaker 5>bites bit or something. I don't necessarily want to speak

0:34:33.200 --> 0:34:35.640
<v Speaker 5>to this, but just thinking of like RBI's for example,

0:34:35.680 --> 0:34:37.160
<v Speaker 5>I think it's owned by a private company, so I

0:34:37.200 --> 0:34:40.680
<v Speaker 5>can you know, talk about without issue. But like the

0:34:40.800 --> 0:34:44.960
<v Speaker 5>prototypical let's just speak theoretically, there's you know, all you

0:34:45.000 --> 0:34:47.400
<v Speaker 5>can eat Biffet or something. They might do really well

0:34:47.680 --> 0:34:50.799
<v Speaker 5>because people eat less, but at the same time they

0:34:50.880 --> 0:34:54.040
<v Speaker 5>might be patronized less because you know, nobody wants all

0:34:54.040 --> 0:34:55.760
<v Speaker 5>you can eat, and you're not getting a good deal anymore.

0:34:56.080 --> 0:34:58.000
<v Speaker 5>So if you have a company and you look at

0:34:58.000 --> 0:35:00.360
<v Speaker 5>the data and basically the way that they make money

0:35:00.480 --> 0:35:02.960
<v Speaker 5>is by selling a ton of food that they get

0:35:03.080 --> 0:35:06.000
<v Speaker 5>very cheaply and make up for you know, kind of

0:35:06.080 --> 0:35:08.720
<v Speaker 5>lower margins by selling a ton of it, that company

0:35:08.719 --> 0:35:10.759
<v Speaker 5>probably isn't going to do too great. But you know,

0:35:10.840 --> 0:35:13.440
<v Speaker 5>it wasn't just metafest for example, you know, going beyond

0:35:13.520 --> 0:35:16.760
<v Speaker 5>the idea of like food being impacted, Like right now,

0:35:17.120 --> 0:35:20.120
<v Speaker 5>Lily has a trial for Munjaro. Basically, what these companies

0:35:20.160 --> 0:35:23.520
<v Speaker 5>are doing is they are on this kind of blitz

0:35:23.520 --> 0:35:26.719
<v Speaker 5>scale for like the data, right because like most of

0:35:26.719 --> 0:35:30.240
<v Speaker 5>these things you can kind of rationally expect, like for example,

0:35:30.280 --> 0:35:33.560
<v Speaker 5>with the Wigobi headline, Gooby reduces heart attack risk by

0:35:33.600 --> 0:35:36.080
<v Speaker 5>twenty percent. I mean kind of like duh, you know,

0:35:36.360 --> 0:35:38.880
<v Speaker 5>like like oh, like you know, if you if you

0:35:39.000 --> 0:35:40.880
<v Speaker 5>go from being obese to not obese, you're going to

0:35:40.920 --> 0:35:42.960
<v Speaker 5>have a lower chance of heart attack. Right. But they

0:35:43.080 --> 0:35:44.960
<v Speaker 5>but what they have to do is you know, have

0:35:45.080 --> 0:35:48.200
<v Speaker 5>these you know, vigorous trials that actually prove it. Like

0:35:48.400 --> 0:35:51.440
<v Speaker 5>so for example, Lily is going right now for obese

0:35:51.480 --> 0:35:55.880
<v Speaker 5>induced sleep ABNA or ni osio or arthritis, and so

0:35:56.360 --> 0:35:58.719
<v Speaker 5>like a company like res Med. Right, ResMed was talking

0:35:58.719 --> 0:36:01.480
<v Speaker 5>about it for you know, like a while on their

0:36:01.520 --> 0:36:05.759
<v Speaker 5>earnings call, and the response was essentially, you know, I'm

0:36:05.800 --> 0:36:07.920
<v Speaker 5>trying to remember exactly what they said, Oh right, a

0:36:08.080 --> 0:36:11.640
<v Speaker 5>seatbad machine. The costs over a lifetime for a seatbad

0:36:11.680 --> 0:36:16.359
<v Speaker 5>machine are like about fifteen thousand dollars. And then they

0:36:16.360 --> 0:36:19.560
<v Speaker 5>did their own math, which was like, well, these GLP

0:36:19.600 --> 0:36:22.480
<v Speaker 5>one drugs cost one thousand dollars a month, and if

0:36:22.480 --> 0:36:24.280
<v Speaker 5>you multiply, if you have a forty year old patient,

0:36:24.360 --> 0:36:27.240
<v Speaker 5>you multiply that by forty years, Well, really a GLP

0:36:27.320 --> 0:36:28.799
<v Speaker 5>one drugs, you know it's going to cost you four

0:36:28.840 --> 0:36:32.359
<v Speaker 5>hundred and eighty thousand dollars. So obviously you know we're

0:36:32.400 --> 0:36:35.840
<v Speaker 5>coming in at fourteen fifteen thousand, where obviously the option

0:36:35.960 --> 0:36:38.000
<v Speaker 5>we're not going to be really affected by this. And

0:36:38.400 --> 0:36:42.080
<v Speaker 5>you know, to take that into consideration, you say, why

0:36:42.120 --> 0:36:44.560
<v Speaker 5>would people be taking this for forty years? Right? Like,

0:36:44.680 --> 0:36:47.320
<v Speaker 5>why would if they if someone you know, seventy percent

0:36:47.320 --> 0:36:49.840
<v Speaker 5>of sleep apne is caused by obesity, If you have

0:36:49.920 --> 0:36:52.719
<v Speaker 5>someone that's taking it and they take it for let's

0:36:52.719 --> 0:36:56.160
<v Speaker 5>say sixteen months and they go from being obese to

0:36:56.280 --> 0:36:59.320
<v Speaker 5>having a normal body weight, and then in all likelihood

0:36:59.320 --> 0:37:02.160
<v Speaker 5>at least for like seventy percent of them, the obstructive

0:37:02.160 --> 0:37:05.160
<v Speaker 5>sleep abne goes away. I mean you have to just

0:37:05.320 --> 0:37:08.239
<v Speaker 5>kind of the total addressable market for a company like

0:37:08.280 --> 0:37:10.720
<v Speaker 5>res med or for the c PAFT industry in general,

0:37:11.120 --> 0:37:14.440
<v Speaker 5>it is going to shrink, right, It's kind of and

0:37:14.600 --> 0:37:16.880
<v Speaker 5>even you know, and then when people say that you

0:37:16.880 --> 0:37:19.240
<v Speaker 5>know this is a fad or you know this won't

0:37:19.239 --> 0:37:21.640
<v Speaker 5>work again, you look at like like when was the

0:37:21.719 --> 0:37:24.960
<v Speaker 5>last fad weight loss drug that had Intuitive Surgical talking

0:37:25.000 --> 0:37:28.279
<v Speaker 5>about on the earnings call? Right, Like Intuitive Surgical they're

0:37:28.320 --> 0:37:29.960
<v Speaker 5>not ready to speak to it, but they mentioned it

0:37:30.000 --> 0:37:31.840
<v Speaker 5>on the earnings call. And then you have another company.

0:37:32.160 --> 0:37:34.600
<v Speaker 5>I think this was my favorite one, right, and it

0:37:34.640 --> 0:37:37.719
<v Speaker 5>wasn't even because of anything the company did or said.

0:37:37.800 --> 0:37:41.600
<v Speaker 5>It was just because I'm reading the prepared remarks and

0:37:42.840 --> 0:37:46.160
<v Speaker 5>the exact text was basically, you know, the company is

0:37:46.200 --> 0:37:49.600
<v Speaker 5>called Teleflex, and it essentially it's a company that makes

0:37:49.640 --> 0:37:52.400
<v Speaker 5>devices for sleeve. But sleeve gets direct to me like

0:37:52.440 --> 0:37:56.320
<v Speaker 5>the bariatric surgery weight loss surgery. You get the sleeve

0:37:57.000 --> 0:38:01.920
<v Speaker 5>and the thing is, you know, sleep gas tractomy. I

0:38:01.920 --> 0:38:04.759
<v Speaker 5>think the average weight loss over seventy two weeks is

0:38:04.800 --> 0:38:09.000
<v Speaker 5>like twenty six or twenty seven percent, And with Munjaro

0:38:09.280 --> 0:38:11.640
<v Speaker 5>it's a little bit closer to depending on the dose,

0:38:11.719 --> 0:38:15.360
<v Speaker 5>between like seventeen and nineteen percent. But Lily's new drug,

0:38:15.640 --> 0:38:18.920
<v Speaker 5>the triple agonist red true Tide, is showing like twenty

0:38:18.960 --> 0:38:22.320
<v Speaker 5>four to twenty five percent. Right, So in the prepared remarks,

0:38:22.320 --> 0:38:25.360
<v Speaker 5>they're basically saying, we did see an effect from GLP

0:38:25.480 --> 0:38:31.040
<v Speaker 5>ones on the demand for bariatric surgery, which affected the

0:38:31.040 --> 0:38:35.839
<v Speaker 5>demand for our device, the Titan stapler. Wait, so if

0:38:35.880 --> 0:38:38.040
<v Speaker 5>I ask you, Tracy, if you want to lose weight,

0:38:38.080 --> 0:38:43.920
<v Speaker 5>would you rather take or get Titan staples? Like? Like,

0:38:43.920 --> 0:38:46.920
<v Speaker 5>like you want to go with the Titan stapler? I

0:38:46.960 --> 0:38:47.360
<v Speaker 5>don't think so.

0:38:47.800 --> 0:38:50.360
<v Speaker 1>Why didn't they call it like suft staple or a

0:38:50.400 --> 0:38:54.240
<v Speaker 1>gentle staple? Titan is just a terrible name for any

0:38:54.280 --> 0:38:58.360
<v Speaker 1>surgical procedure. Okay, Wait, So one of the reasons talking

0:38:58.400 --> 0:39:00.759
<v Speaker 1>about this is fun is because it is kind of

0:39:00.840 --> 0:39:05.600
<v Speaker 1>a giant thought experiment of what a world of fewer

0:39:05.640 --> 0:39:10.160
<v Speaker 1>obese people would actually mean. How far can you take it? James,

0:39:10.200 --> 0:39:14.000
<v Speaker 1>like to, what's your most interesting sort of second order

0:39:14.440 --> 0:39:18.920
<v Speaker 1>trade idea based on a widely available weight loss drug.

0:39:20.200 --> 0:39:22.160
<v Speaker 5>Well, I think that you know, if I'm going to

0:39:22.200 --> 0:39:24.080
<v Speaker 5>stretch this as you know, as far as it can go,

0:39:24.280 --> 0:39:26.080
<v Speaker 5>the first thing is stretching it as far as it

0:39:26.080 --> 0:39:29.520
<v Speaker 5>can go gets pretty stretched because I mean, the direct

0:39:29.600 --> 0:39:31.239
<v Speaker 5>medical costs this year from obessie, they're going to be

0:39:31.280 --> 0:39:34.200
<v Speaker 5>three hundred and seventy billion dollars. The indirect costs are

0:39:34.200 --> 0:39:37.440
<v Speaker 5>going to be over a trillion. McKinsey in twenty twelve,

0:39:37.440 --> 0:39:39.560
<v Speaker 5>when the OBCD rate was like I want to say,

0:39:39.600 --> 0:39:43.000
<v Speaker 5>seven or eight percent lower, they estimated that OBESD results

0:39:43.040 --> 0:39:47.440
<v Speaker 5>in an annual global an annual global economic impact that

0:39:47.600 --> 0:39:50.800
<v Speaker 5>is equivalent to two point eight percent of the global GDP.

0:39:51.600 --> 0:39:54.319
<v Speaker 5>So you think about like productivity six days, you know,

0:39:54.400 --> 0:39:59.160
<v Speaker 5>workers comp injury, I mean life insurance, health insurance, workers

0:39:59.200 --> 0:40:02.160
<v Speaker 5>comp insurance. It something like that. When you have a

0:40:02.320 --> 0:40:04.760
<v Speaker 5>when you have a literal disease state that is affecting

0:40:04.840 --> 0:40:07.759
<v Speaker 5>forty two percent of your population, it's kind of hard

0:40:07.840 --> 0:40:09.719
<v Speaker 5>not to stretch this far, you know, like like if

0:40:09.719 --> 0:40:13.200
<v Speaker 5>that gets fixed. But in terms of the one that

0:40:13.200 --> 0:40:15.680
<v Speaker 5>I would share on a podcast to be entertaining, I

0:40:15.719 --> 0:40:19.719
<v Speaker 5>would say, like match group or bumble as along. If

0:40:19.760 --> 0:40:22.880
<v Speaker 5>you look into like just general, everyone feels.

0:40:23.320 --> 0:40:26.640
<v Speaker 4>Themselves and so they get to advertise them that's in

0:40:26.680 --> 0:40:28.759
<v Speaker 4>a product in the dating marketplace.

0:40:29.480 --> 0:40:32.720
<v Speaker 5>And you know what's interesting about this, you know, match group.

0:40:32.840 --> 0:40:35.279
<v Speaker 5>I already think that the fundamentals look good here, but

0:40:36.200 --> 0:40:38.279
<v Speaker 5>you know, if we're going to like stretch it super far,

0:40:38.400 --> 0:40:40.319
<v Speaker 5>you look at like match groups last earnings and like

0:40:40.719 --> 0:40:43.440
<v Speaker 5>payers were flat or decreased a little bit for tender,

0:40:43.920 --> 0:40:47.600
<v Speaker 5>but they increase significantly for hinge. And if you look

0:40:47.600 --> 0:40:50.440
<v Speaker 5>at like there are like, you know, social sciences studies

0:40:50.440 --> 0:40:53.520
<v Speaker 5>about like the effects of obesity on like your how

0:40:53.560 --> 0:40:55.400
<v Speaker 5>happy you are and how satisfied you are with your

0:40:55.480 --> 0:40:58.080
<v Speaker 5>dating life and stuff, And I think, I don't want

0:40:58.080 --> 0:41:01.040
<v Speaker 5>to butcher the results or something, but it was basically

0:41:01.640 --> 0:41:05.840
<v Speaker 5>across genders, right, like if you are female or male,

0:41:06.480 --> 0:41:10.200
<v Speaker 5>the effect of losing ten or twenty pounds on your

0:41:10.280 --> 0:41:13.120
<v Speaker 5>average you know, satisfaction with your dating life and with

0:41:13.360 --> 0:41:15.399
<v Speaker 5>just generally how happy you are. It's a lot more

0:41:15.440 --> 0:41:20.040
<v Speaker 5>significant in females. So you know, maybe if you want

0:41:20.040 --> 0:41:22.200
<v Speaker 5>to like be super early and stretch it super far.

0:41:22.320 --> 0:41:24.680
<v Speaker 5>Maybe the reason that like hinge is getting more popular

0:41:24.719 --> 0:41:27.560
<v Speaker 5>than tendered. Maybe it's because it's easier to lose weight.

0:41:27.600 --> 0:41:30.040
<v Speaker 5>I don't I would not say that in like an

0:41:30.040 --> 0:41:36.080
<v Speaker 5>authoritative way, but you know, I just say, yeah, that's

0:41:36.120 --> 0:41:39.960
<v Speaker 5>that's the thing. I'm going to get quoted a like, No,

0:41:40.400 --> 0:41:43.120
<v Speaker 5>this is a crazy guy thinks that, like match group

0:41:43.200 --> 0:41:45.040
<v Speaker 5>is going to moon because of you know, No, I

0:41:45.040 --> 0:41:46.759
<v Speaker 5>guess I just say I get, I get how the

0:41:46.800 --> 0:41:50.560
<v Speaker 5>internet works, though this is I know, I know it's funny.

0:41:50.560 --> 0:41:52.680
<v Speaker 4>I keep reading through conference calls after you mentioned them.

0:41:52.719 --> 0:41:54.840
<v Speaker 4>I'm looking at the res mid one and did you

0:41:54.880 --> 0:41:58.160
<v Speaker 4>look at Titan State, But they're talking about They're like, well,

0:41:58.320 --> 0:42:01.040
<v Speaker 4>they're like because clearly this is a source of anxiety

0:42:01.080 --> 0:42:03.319
<v Speaker 4>for them. So they're like, oh, well, like uptake and

0:42:03.400 --> 0:42:05.640
<v Speaker 4>like endherance is not really that good. And then a

0:42:05.760 --> 0:42:08.319
<v Speaker 4>very funny thing they say, because Biden had that mark

0:42:08.360 --> 0:42:10.760
<v Speaker 4>on his face is our biggest side effect is President

0:42:10.760 --> 0:42:12.680
<v Speaker 4>Biden had a little mark on his face and he

0:42:12.800 --> 0:42:15.000
<v Speaker 4>was asked about it and it was from his CEPAP.

0:42:15.520 --> 0:42:15.759
<v Speaker 5>Look.

0:42:15.760 --> 0:42:17.440
<v Speaker 4>I think it's a good long road to play out here.

0:42:17.480 --> 0:42:20.479
<v Speaker 4>I think it's frankly good marketing. So President Biden, because

0:42:20.520 --> 0:42:22.200
<v Speaker 4>he had to put a device on his face for

0:42:22.280 --> 0:42:23.640
<v Speaker 4>his sleep problems.

0:42:23.719 --> 0:42:26.399
<v Speaker 5>The company is setting it market, did we just I mean,

0:42:27.320 --> 0:42:30.360
<v Speaker 5>I saw I saw a photo of Justin Trudeau at Imax,

0:42:30.840 --> 0:42:32.240
<v Speaker 5>so maybe I should get long Imax.

0:42:32.719 --> 0:42:35.839
<v Speaker 4>You know, it seems like a big deal, like just

0:42:36.120 --> 0:42:38.640
<v Speaker 4>zooming out. It seems like a big deal. Even if

0:42:38.640 --> 0:42:40.239
<v Speaker 4>we like set aside what it's going to do to

0:42:40.239 --> 0:42:42.560
<v Speaker 4>PEPSI or what it's going to do to like freedom

0:42:42.600 --> 0:42:44.239
<v Speaker 4>lay or that's the same, you know, what it's going

0:42:44.280 --> 0:42:47.359
<v Speaker 4>to do to all these consumer companies, you know, health insurance.

0:42:47.640 --> 0:42:52.960
<v Speaker 4>You mentioned that like obesity plus obesity related diseases are huge,

0:42:53.239 --> 0:42:54.799
<v Speaker 4>and so if they were to go down and you

0:42:54.840 --> 0:42:56.879
<v Speaker 4>see maybe you see some of that in the sort

0:42:56.880 --> 0:42:59.480
<v Speaker 4>of weak stock price of res med anxiety about this?

0:43:00.040 --> 0:43:02.799
<v Speaker 4>What does it mean just like for like health insurers

0:43:03.040 --> 0:43:06.719
<v Speaker 4>and also just like healthcare utilization in general, Like you know,

0:43:06.880 --> 0:43:09.520
<v Speaker 4>generally we think of like healthcare as like a line

0:43:09.560 --> 0:43:12.319
<v Speaker 4>that only goes up that if you're a healthcare professional,

0:43:12.360 --> 0:43:15.920
<v Speaker 4>you're like gonna do very probably likely very well guaranteed demand.

0:43:16.360 --> 0:43:18.000
<v Speaker 4>What is the effect on just sort of like the

0:43:18.040 --> 0:43:21.080
<v Speaker 4>broader healthcare institutional healthcare industry.

0:43:22.040 --> 0:43:24.239
<v Speaker 5>Since you've already got documents search slouded up, why don't

0:43:24.239 --> 0:43:28.520
<v Speaker 5>you check out Insparity. The ticker is a NSP.

0:43:28.960 --> 0:43:29.839
<v Speaker 2>This is a fun guy.

0:43:30.320 --> 0:43:32.840
<v Speaker 4>I was like just hearing different names and then I

0:43:32.840 --> 0:43:34.200
<v Speaker 4>look at looked them up during the answer.

0:43:34.200 --> 0:43:34.799
<v Speaker 2>But yeah, keep going.

0:43:34.880 --> 0:43:38.640
<v Speaker 5>Welcome to my life during earning season. Document search is

0:43:38.680 --> 0:43:42.600
<v Speaker 5>my favorite feature. But you know, if you look at Inspirity,

0:43:42.880 --> 0:43:45.560
<v Speaker 5>you can kind of see. I don't want to misquote anyone,

0:43:45.680 --> 0:43:47.440
<v Speaker 5>so I'll just put it up very quickly.

0:43:48.120 --> 0:43:49.440
<v Speaker 3>Look at the share price.

0:43:49.840 --> 0:43:53.360
<v Speaker 4>Hey, this is the company offers recruiting, employment screen and

0:43:53.400 --> 0:43:54.600
<v Speaker 4>retirement business insurance.

0:43:54.640 --> 0:43:56.040
<v Speaker 2>Yeah, what is this company?

0:43:56.160 --> 0:43:57.720
<v Speaker 1>It's down about sixteen percent.

0:43:57.800 --> 0:43:59.920
<v Speaker 2>That's what matters. I can't figure out what they do

0:44:00.040 --> 0:44:01.080
<v Speaker 2>and what their connection is here.

0:44:01.120 --> 0:44:01.600
<v Speaker 5>So we're going to.

0:44:01.680 --> 0:44:05.520
<v Speaker 1>Find out human resources and business optimizations.

0:44:05.600 --> 0:44:09.160
<v Speaker 2>No, no, no, yeah, but I don't so what's the here.

0:44:09.280 --> 0:44:11.319
<v Speaker 5>So here's the deal, right. They also offer you know,

0:44:11.400 --> 0:44:14.880
<v Speaker 5>employed benefit administration, which you know, like like health and

0:44:15.400 --> 0:44:18.000
<v Speaker 5>so if you want to boil it down to two things, like,

0:44:18.040 --> 0:44:20.279
<v Speaker 5>Insparity got hit on the fact that like people want

0:44:20.280 --> 0:44:22.239
<v Speaker 5>these drugs because they don't want to be fat and

0:44:22.320 --> 0:44:25.760
<v Speaker 5>the drugs make them not fat, and Insparity apparently thinks

0:44:25.800 --> 0:44:28.160
<v Speaker 5>that you know, that is a fad. They were saying

0:44:28.200 --> 0:44:30.200
<v Speaker 5>something that was like, oh, you know, the effects are

0:44:30.239 --> 0:44:32.719
<v Speaker 5>going to wane because of the side effects. And when

0:44:32.760 --> 0:44:35.400
<v Speaker 5>you think about it, like these drugs were originally developed

0:44:35.400 --> 0:44:37.040
<v Speaker 5>for type two diabetes, and it's like, oh, you know,

0:44:37.360 --> 0:44:39.360
<v Speaker 5>there's never been a drug before that was developed for

0:44:39.440 --> 0:44:41.080
<v Speaker 5>one thing and then ended up being really good for

0:44:41.080 --> 0:44:43.360
<v Speaker 5>the other, you know, just like Tracy said with Viagra.

0:44:43.920 --> 0:44:46.880
<v Speaker 5>And basically they said, you know, large claim activity accounted

0:44:46.880 --> 0:44:49.360
<v Speaker 5>for approximately seventy five percent of the higher costs with

0:44:49.440 --> 0:44:53.160
<v Speaker 5>claims over seven hundred and fifty thousand dollars, and the

0:44:53.200 --> 0:44:56.600
<v Speaker 5>remaining twenty five percent is related to higher than expected

0:44:56.640 --> 0:44:59.759
<v Speaker 5>pharmacy costs. As for higher pharmacy costs, we experienced an

0:44:59.800 --> 0:45:03.120
<v Speaker 5>in increase and utilization of the specialty drugs, including a

0:45:03.200 --> 0:45:05.600
<v Speaker 5>significant step up in the use of diabetes and weight

0:45:05.640 --> 0:45:08.880
<v Speaker 5>loss drugs. And then they talk about behavioral health drugs

0:45:08.880 --> 0:45:12.880
<v Speaker 5>to behavioral health drugs too, which is probably you know,

0:45:12.920 --> 0:45:15.000
<v Speaker 5>I mean, I don't know, that's a whole different conversation

0:45:15.080 --> 0:45:17.359
<v Speaker 5>with COVID and behavioral health drugs. And you know, like

0:45:17.600 --> 0:45:20.880
<v Speaker 5>how people have emotionally reacted to the last three years.

0:45:20.920 --> 0:45:23.800
<v Speaker 5>But when you look at it, for insparity. It's probably

0:45:23.840 --> 0:45:26.319
<v Speaker 5>bad right now because you know, as long as these

0:45:26.360 --> 0:45:29.879
<v Speaker 5>companies have a duopoly on these drugs, the cost will

0:45:29.920 --> 0:45:32.600
<v Speaker 5>probably be hot. But that can only last for so long.

0:45:32.680 --> 0:45:36.600
<v Speaker 5>You know that eventually there will be competition. Eventually the

0:45:36.600 --> 0:45:39.279
<v Speaker 5>cost will go down. Eventually it'll be like Biagra, where

0:45:39.320 --> 0:45:41.040
<v Speaker 5>it goes from you know, eighty eight dollars pill to

0:45:41.600 --> 0:45:44.279
<v Speaker 5>whatever two dollars a pill. Maybe it was bad quarter

0:45:44.360 --> 0:45:46.839
<v Speaker 5>for insparity. Maybe that continues for a little bit while

0:45:46.840 --> 0:45:48.880
<v Speaker 5>they're still expensive, and then eventually it'll get better. But

0:45:48.920 --> 0:45:51.400
<v Speaker 5>when you think of it from let's say Signa or

0:45:52.239 --> 0:45:54.920
<v Speaker 5>United Healthcare Signa on their earnings called they said, you know,

0:45:55.000 --> 0:45:57.840
<v Speaker 5>GLP ones are definitely top of mind for many of

0:45:57.880 --> 0:46:01.319
<v Speaker 5>our clients. There's been a meaningful upticking utils station. And

0:46:02.920 --> 0:46:07.000
<v Speaker 5>essentially what they said was, you know, there's a continued

0:46:07.040 --> 0:46:10.160
<v Speaker 5>interest in behavioral solutions. You know, these insurance companies they

0:46:10.160 --> 0:46:11.960
<v Speaker 5>will like pay for you to get a gym membership,

0:46:12.040 --> 0:46:14.319
<v Speaker 5>or they'll pay for you to get a meal plan

0:46:14.440 --> 0:46:17.760
<v Speaker 5>or something, and the success rates of those things are dismal,

0:46:18.400 --> 0:46:22.120
<v Speaker 5>like absolutely awful, right and you know it doesn't work.

0:46:22.440 --> 0:46:26.480
<v Speaker 5>And insurance companies are stakeholders in global health, right, and

0:46:26.760 --> 0:46:29.719
<v Speaker 5>they're really good and anticipating how much it's going to

0:46:29.800 --> 0:46:31.759
<v Speaker 5>cost and making sure, you know that they make more

0:46:31.800 --> 0:46:36.080
<v Speaker 5>money than what it's going to cost. But as an epidemic,

0:46:36.320 --> 0:46:39.360
<v Speaker 5>this is still like a relatively new thing. The obesity

0:46:39.440 --> 0:46:42.759
<v Speaker 5>rate has never been forty two percent before, and so

0:46:42.840 --> 0:46:45.879
<v Speaker 5>what do how can we really accurately model what that's

0:46:45.880 --> 0:46:48.520
<v Speaker 5>going to look like in fifty years? I mean, you know,

0:46:48.640 --> 0:46:51.160
<v Speaker 5>maybe if it continues the way that it's going unobated,

0:46:51.320 --> 0:46:55.440
<v Speaker 5>I think that ultimately, you know, health insurance that it's

0:46:55.440 --> 0:46:57.640
<v Speaker 5>going to be a significant hit. So what you're seeing

0:46:57.760 --> 0:47:02.080
<v Speaker 5>is these drug drug companies essentially going on these data campaigns,

0:47:02.120 --> 0:47:03.759
<v Speaker 5>which is, you know, we're going to show you not

0:47:03.920 --> 0:47:06.120
<v Speaker 5>just that it results in weight loss. We're going to

0:47:06.160 --> 0:47:09.240
<v Speaker 5>do a study and a clinical trial on every single

0:47:09.239 --> 0:47:11.920
<v Speaker 5>one of the beneficial effects of losing weight. Right, We're

0:47:11.960 --> 0:47:16.279
<v Speaker 5>going to say, oh, obstructive sleep, at hyper lipidemia, hypertension,

0:47:16.360 --> 0:47:20.480
<v Speaker 5>heart disease, type two diabetes, knee replacements, all of this stuff.

0:47:20.520 --> 0:47:24.600
<v Speaker 5>And then eventually it is for Signa or for United Healthcare,

0:47:24.640 --> 0:47:27.560
<v Speaker 5>it is going to be They're they're going to do

0:47:27.560 --> 0:47:30.000
<v Speaker 5>what insurance companies do. They're going to negotiate. They're going

0:47:30.080 --> 0:47:32.160
<v Speaker 5>to push down the price. They're gonna you know, they're

0:47:32.200 --> 0:47:34.960
<v Speaker 5>gonna there's going to be pushback. There's going to be

0:47:36.000 --> 0:47:38.720
<v Speaker 5>what cut gets covered and what doesn't, especially after Munjara

0:47:38.760 --> 0:47:41.279
<v Speaker 5>gets approved for OBCD. But at the end of the day,

0:47:41.920 --> 0:47:45.319
<v Speaker 5>the thing is they are basically going to have to

0:47:45.600 --> 0:47:48.319
<v Speaker 5>do a cost benefit analysis, and there is no way

0:47:48.320 --> 0:47:50.879
<v Speaker 5>in my mind, I think really even if they were

0:47:50.880 --> 0:47:53.479
<v Speaker 5>paying one hundred and fifty percent of what Lily's charging

0:47:53.480 --> 0:47:55.799
<v Speaker 5>and didn't negotiate at all, over the course of the

0:47:55.800 --> 0:47:59.000
<v Speaker 5>next twenty or thirty years, they would probably make money.

0:47:59.320 --> 0:48:03.120
<v Speaker 5>Like they would probably be a better situation than it

0:48:03.160 --> 0:48:05.440
<v Speaker 5>would be without it, you know, not to get too

0:48:05.760 --> 0:48:10.680
<v Speaker 5>like insanely off the rails. But again, it's a podcast, so.

0:48:10.400 --> 0:48:12.920
<v Speaker 1>This thing is experiment, So let's do it.

0:48:13.040 --> 0:48:15.839
<v Speaker 5>Let's entertain some people. Right, why shouldn't the government pay

0:48:15.880 --> 0:48:16.120
<v Speaker 5>for this?

0:48:17.000 --> 0:48:20.480
<v Speaker 4>Well, you mentioned that the Inflation Reduction Act is going

0:48:20.520 --> 0:48:22.479
<v Speaker 4>to reduce the cost. This should be Biden's re election.

0:48:22.640 --> 0:48:24.359
<v Speaker 4>He's like, hey, I signed the bill that's given.

0:48:26.360 --> 0:48:31.600
<v Speaker 5>Yeah, let's look, let's look at this. Right. We just

0:48:31.640 --> 0:48:34.040
<v Speaker 5>had like the biggest public health experiment ever. You know,

0:48:34.080 --> 0:48:36.799
<v Speaker 5>we had COVID. Right, Like, how many does anyone know

0:48:36.800 --> 0:48:38.560
<v Speaker 5>off the top of their head how many people COVID?

0:48:38.680 --> 0:48:42.160
<v Speaker 5>I don't, that's not a fact that I have handy,

0:48:42.560 --> 0:48:46.719
<v Speaker 5>but right, but and how many people? What was the

0:48:46.800 --> 0:48:51.320
<v Speaker 5>all cause mortality of like COVID in like annually during

0:48:51.360 --> 0:48:55.320
<v Speaker 5>like the peak of the epidemic. It was probably high.

0:48:55.480 --> 0:48:58.240
<v Speaker 5>But what I'll tell you is it probably was similar

0:48:58.320 --> 0:49:00.319
<v Speaker 5>to how many people are going to dive over city

0:49:00.360 --> 0:49:03.000
<v Speaker 5>this year. You know, I don't want to like speak

0:49:03.040 --> 0:49:05.480
<v Speaker 5>without facts in front of me, but I would say,

0:49:05.560 --> 0:49:08.040
<v Speaker 5>you know, if if someone wants to go look that

0:49:08.200 --> 0:49:11.840
<v Speaker 5>up and you know, whether it's how many people divebcity

0:49:11.920 --> 0:49:13.799
<v Speaker 5>this year or how many and five years, I would

0:49:13.840 --> 0:49:18.600
<v Speaker 5>say that they are probably comparable public health crises. And

0:49:18.840 --> 0:49:21.480
<v Speaker 5>also in terms of the impact on the economy. Obviously,

0:49:21.480 --> 0:49:24.480
<v Speaker 5>nothing can rival shutting down the entire economy and you know,

0:49:24.560 --> 0:49:28.239
<v Speaker 5>having a lockdown. But if you look at it from

0:49:28.239 --> 0:49:31.279
<v Speaker 5>a cube versus chronic perspective, you know, if obesity is

0:49:31.280 --> 0:49:33.480
<v Speaker 5>going to cost us a trillion dollars this year in

0:49:33.480 --> 0:49:36.680
<v Speaker 5>indirect costs, and we're running it a trillion dollars a year,

0:49:37.400 --> 0:49:40.279
<v Speaker 5>I mean over the next ten years, like what it

0:49:40.400 --> 0:49:43.200
<v Speaker 5>just seems like something where it let's say that you know,

0:49:43.280 --> 0:49:45.880
<v Speaker 5>Lily and Novo and all the other companies that eventually

0:49:45.960 --> 0:49:49.520
<v Speaker 5>join the FRAY that they're effective in proving that the

0:49:49.600 --> 0:49:54.759
<v Speaker 5>side effects are moderate and that the overall benefit is sustained,

0:49:54.800 --> 0:49:57.680
<v Speaker 5>and it's good. Why would the government not cover it? Right? Like,

0:49:57.840 --> 0:50:00.839
<v Speaker 5>if they're if they'll cover COVID vaccine, should probably cover

0:50:00.880 --> 0:50:03.120
<v Speaker 5>this too, especially if it has a twenty percent production

0:50:03.320 --> 0:50:04.239
<v Speaker 5>like heart attacks.

0:50:04.320 --> 0:50:08.680
<v Speaker 1>I mean, well, I would never overestimate America's ability to

0:50:08.719 --> 0:50:11.000
<v Speaker 1>make bad decisions when it comes to public health care.

0:50:11.160 --> 0:50:12.520
<v Speaker 5>But that's a good point.

0:50:13.200 --> 0:50:17.719
<v Speaker 1>But James, that was a really fun conversation. Absolutely a

0:50:17.760 --> 0:50:19.840
<v Speaker 1>blast to have you on and go through the transcript

0:50:19.920 --> 0:50:21.839
<v Speaker 1>sort of in real time while we're talking to you.

0:50:22.120 --> 0:50:22.680
<v Speaker 3>That was great.

0:50:23.760 --> 0:50:26.839
<v Speaker 5>Absolutely, And you know, if you want to learn more,

0:50:27.080 --> 0:50:29.680
<v Speaker 5>you know, I've been writing about this since June on

0:50:30.000 --> 0:50:33.200
<v Speaker 5>is suctriniresearch dot com. I go pretty deep into these

0:50:33.239 --> 0:50:37.160
<v Speaker 5>I did want on a yeah, oh you you read it,

0:50:37.200 --> 0:50:38.640
<v Speaker 5>Come on, we do a little.

0:50:39.120 --> 0:50:40.600
<v Speaker 1>There's much believe it or not.

0:50:40.640 --> 0:50:42.279
<v Speaker 2>There is something that I read it.

0:50:42.200 --> 0:50:44.400
<v Speaker 4>On the subway this morning while coming in. I do

0:50:44.520 --> 0:50:45.560
<v Speaker 4>real prep for this job.

0:50:46.120 --> 0:50:48.120
<v Speaker 5>I send it to you like twelve hours beforehand, and

0:50:48.200 --> 0:50:50.360
<v Speaker 5>I know it's like, you know, twenty pages long, so

0:50:50.960 --> 0:50:51.799
<v Speaker 5>I would have forgived you.

0:50:53.080 --> 0:50:54.799
<v Speaker 1>All right, well, James, thanks so much for coming on

0:50:54.840 --> 0:50:55.960
<v Speaker 1>all thoughts. Appreciate it.

0:50:56.640 --> 0:50:57.879
<v Speaker 5>Thank you so much for having me guys.

0:50:58.000 --> 0:50:59.040
<v Speaker 2>Thanks James, that was a blast.

0:51:12.080 --> 0:51:14.480
<v Speaker 1>All right, well, Joe, I for one look forward to

0:51:14.560 --> 0:51:18.880
<v Speaker 1>the spelt future of publicly funded weight loss drugs.

0:51:19.120 --> 0:51:21.160
<v Speaker 4>I mean, I totally like, why not if all the

0:51:21.239 --> 0:51:25.120
<v Speaker 4>things seem to be true about this what many people

0:51:25.160 --> 0:51:27.920
<v Speaker 4>seem to believe. And you know, it's like James is

0:51:27.960 --> 0:51:29.840
<v Speaker 4>like totally right, Like you see a lot of people

0:51:29.840 --> 0:51:32.359
<v Speaker 4>like poking there, like there must be some catch here, right,

0:51:32.560 --> 0:51:34.520
<v Speaker 4>there must be just gonna melt your insides or it's

0:51:34.520 --> 0:51:37.200
<v Speaker 4>gonna do something. Maybe one day, you never know, but

0:51:38.040 --> 0:51:40.400
<v Speaker 4>right now, anything I read about the side effects never

0:51:40.480 --> 0:51:41.919
<v Speaker 4>seemed like that compelling or anything.

0:51:41.960 --> 0:51:43.760
<v Speaker 2>And he just point out the classic drugs for a while,

0:51:44.120 --> 0:51:44.640
<v Speaker 2>it kind.

0:51:44.520 --> 0:51:47.680
<v Speaker 4>Of feels like potentially like a legit miracle drug, right,

0:51:47.800 --> 0:51:48.720
<v Speaker 4>Like it's kind of wild.

0:51:48.760 --> 0:51:50.600
<v Speaker 1>Well, I think he makes an excellent point about the

0:51:50.640 --> 0:51:52.719
<v Speaker 1>trade offs, right, and at some point it might be

0:51:52.800 --> 0:51:55.520
<v Speaker 1>cheaper for an insurance company to just provide this drug

0:51:55.760 --> 0:51:59.120
<v Speaker 1>rather than treat someone for diabetes or heart problems or

0:51:59.160 --> 0:52:02.320
<v Speaker 1>sleep apnea or whatever else for the rest of their lives.

0:52:02.520 --> 0:52:04.520
<v Speaker 1>The other thing I was thinking throughout all of that,

0:52:04.560 --> 0:52:07.520
<v Speaker 1>you know, I initially came into the conversation thinking like,

0:52:07.600 --> 0:52:12.040
<v Speaker 1>oh wow, if everyone's consuming less, yeah, maybe that's deflationary.

0:52:12.280 --> 0:52:15.440
<v Speaker 1>But now I'm going back to that price over volume

0:52:15.680 --> 0:52:19.080
<v Speaker 1>oh theme. And James brought it up as well, which is, well,

0:52:19.160 --> 0:52:22.440
<v Speaker 1>if you're Wendy's and people just aren't buying as many cheeseburgers,

0:52:22.480 --> 0:52:25.280
<v Speaker 1>then maybe you just raise your prices to offset it.

0:52:25.320 --> 0:52:27.960
<v Speaker 4>Could be the I am cures. I mean, there's all

0:52:28.040 --> 0:52:30.279
<v Speaker 4>kinds of like other things that we could get into. Yeah,

0:52:30.320 --> 0:52:32.760
<v Speaker 4>and so another thing, and I saw someone on Twitter

0:52:32.800 --> 0:52:36.160
<v Speaker 4>say this, They're like, well, well, the snack companies put

0:52:36.239 --> 0:52:38.040
<v Speaker 4>even more salt.

0:52:37.840 --> 0:52:39.759
<v Speaker 2>And other addicting type of.

0:52:39.719 --> 0:52:43.800
<v Speaker 4>Like ingredients to counter setting the people who aren't taking

0:52:44.480 --> 0:52:46.759
<v Speaker 4>the drugs buy even more in the future, Like they're

0:52:46.800 --> 0:52:48.439
<v Speaker 4>not going to give up without a fight if there's

0:52:48.440 --> 0:52:51.200
<v Speaker 4>some drug that causes people, you know, like everyone's gonna

0:52:51.239 --> 0:52:53.399
<v Speaker 4>like try to like find some way. We didn't talk

0:52:53.400 --> 0:52:56.600
<v Speaker 4>about gyms really, but I wonder like, like one way

0:52:56.600 --> 0:52:58.400
<v Speaker 4>of thinking is maybe it's bad for gyms. But on

0:52:58.440 --> 0:53:00.680
<v Speaker 4>the other hand, like if maybe one to show off,

0:53:00.840 --> 0:53:03.360
<v Speaker 4>that's exactly right. If you feel more confident, then maybe,

0:53:03.400 --> 0:53:05.000
<v Speaker 4>like you know what, I'm ready to I don't mind

0:53:05.040 --> 0:53:07.520
<v Speaker 4>being seen at the gym. All kinds of interesting questions,

0:53:07.520 --> 0:53:09.680
<v Speaker 4>Like I like the idea of like, you know, Madge

0:53:09.760 --> 0:53:12.600
<v Speaker 4>or Hinge is a bye or is like a winner here?

0:53:12.680 --> 0:53:15.640
<v Speaker 4>So that was a very fun thought insperiment, and it

0:53:15.680 --> 0:53:17.840
<v Speaker 4>was fun in the context that he knew so many details,

0:53:17.840 --> 0:53:19.279
<v Speaker 4>so it was like also kind of real nudges.

0:53:19.440 --> 0:53:21.640
<v Speaker 1>Yeah, and I'm going to spend I think the next

0:53:21.760 --> 0:53:23.960
<v Speaker 1>like two hours or so just going through some of

0:53:23.960 --> 0:53:26.440
<v Speaker 1>the Earnings transcripts and saying what people are saying about this,

0:53:26.440 --> 0:53:29.920
<v Speaker 1>because I hadn't realized that people were already actually talking

0:53:29.960 --> 0:53:30.359
<v Speaker 1>about it.

0:53:30.600 --> 0:53:33.120
<v Speaker 4>Well, so I think the reason I didn't realize it

0:53:33.160 --> 0:53:35.600
<v Speaker 4>is because I was searching azimbic. It's just like the

0:53:35.640 --> 0:53:39.360
<v Speaker 4>thing all searching. You just search GLP and then tons

0:53:39.440 --> 0:53:41.560
<v Speaker 4>come up, and so it's really interesting. I mean, it's

0:53:41.560 --> 0:53:43.719
<v Speaker 4>a huge focus on a lot of these calls just

0:53:43.760 --> 0:53:44.480
<v Speaker 4>from looking it up.

0:53:44.560 --> 0:53:47.200
<v Speaker 1>All right, well, fun conversation. Shall we leave it there,

0:53:47.280 --> 0:53:50.000
<v Speaker 1>Let's leave it there? Okay, this has been another episode

0:53:50.040 --> 0:53:52.879
<v Speaker 1>of the All Thoughts podcast. I'm Tracy Alloway. You can

0:53:52.880 --> 0:53:54.920
<v Speaker 1>follow me on Twitter at Tracy Alloway.

0:53:55.160 --> 0:53:58.120
<v Speaker 4>And I'm Jill Wisenthal. You can follow me on Twitter

0:53:58.239 --> 0:54:01.360
<v Speaker 4>at The Stalwart. You can follow Hello James Van Galen

0:54:01.800 --> 0:54:05.640
<v Speaker 4>on Twitter at sutrini seven. Also check out his research.

0:54:06.040 --> 0:54:09.680
<v Speaker 4>Follow our producers Carmen Rodriguez at Carman Arman and dash

0:54:09.719 --> 0:54:12.800
<v Speaker 4>O Bennett at dashbot and all of the Bloomberg podcasts

0:54:12.800 --> 0:54:15.960
<v Speaker 4>can be found under the handle at podcasts. And for

0:54:16.080 --> 0:54:19.000
<v Speaker 4>more odd Loots content, go to Bloomberg dot com slash

0:54:19.120 --> 0:54:21.840
<v Speaker 4>odd Lots where we have a transcript.

0:54:21.239 --> 0:54:24.000
<v Speaker 2>Blog in a newsletter and we don't have.

0:54:23.960 --> 0:54:25.960
<v Speaker 4>A pharmaceutical channel and there maybe we've got to add

0:54:25.960 --> 0:54:28.360
<v Speaker 4>a medicine and health one. But check out the discord,

0:54:28.840 --> 0:54:30.920
<v Speaker 4>one of my favorite places to hang out on the internet.

0:54:31.320 --> 0:54:34.160
<v Speaker 4>Other odd Lots listeners are there talking twenty four to seven,

0:54:34.880 --> 0:54:36.480
<v Speaker 4>Discord dot g slash on.

0:54:37.120 --> 0:54:40.160
<v Speaker 1>And if you enjoy odd Lots, if you like listening

0:54:40.400 --> 0:54:44.440
<v Speaker 1>to these types of conversations imagining a world without obesity,

0:54:44.840 --> 0:54:47.880
<v Speaker 1>then do leave us a positive review on your favorite

0:54:47.880 --> 0:54:49.000
<v Speaker 1>podcast platform.

0:54:49.040 --> 0:55:15.920
<v Speaker 3>Thanks for listening. In a